Plataforma de Unidades de Investigación Clínica y Ensayos Clínicos.

Letter. 10.1111/jdv.16664. 2020

A critical review of the 2020 International Liaison Committee on Resuscitation treatment recommendations for resuscitating the newly born infant.

Saugstad, Ola D., Robertson, Nicola J., Vento, Maximo

Review. 10.1111/apa.15754. 2021

A multi-centre randomised controlled trial of respiratory function monitoring during stabilisation of very preterm infants at birth.

van Zanten, Henriette A.; (...); te Pas, Arjan B.

Article. 10.1016/j.resuscitation.2021.07.012. 2021

A Nomogram Combining Fecal Calprotectin Levels and Plasma Cytokine Profiles for Individual Prediction of Postoperative Crohn's Disease Recurrence.

Cerrillo E; (...); Beltrán B

Article. 10.1093/ibd/izz053. 2019

A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia

Onecha, E; (...); Ayala, R

Article. 10.3324/haematol.2018.194712. 2019

A pediatric regimen for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial.

Ribera JM; (...); Orfao A

Article. 10.1002/cam4.2814. 2020

A Phase 1 Study of Flotetuzumab, a CD123 x CD3 DART (R) Protein, Combined with MGA012, an Anti-PD-1 Antibody, in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Wei, Andrew H.; (...); Davidson-Moncada, Jan K.

Meeting Abstract. 10.1182/blood-2019-125966. 2019

A Phase 1b/2 Study of the CD123-Targeting Antibody-Drug Conjugate IMGN632 As Monotherapy or in Combination with Venetoclax and Azacitidine for Patients with CD123-Positive Acute Myeloid Leukemia

Daver, Naval; (...); Sweet, Kendra

Meeting Abstract. 10.1182/blood-2021-146585. 2021

A Phase 3 Randomized Study (PRIMULA) of the Epigenetic Combination of Pracinostat, a Pan-Histone Deacetylase (HDAC) Inhibitor, with Azacitidine (AZA) in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Unfit for Standard Intensive Chemotherapy (IC)

Garcia-Manero, Guillermo; (...); Ades, Lionel

Meeting Abstract. 10.1182/blood-2019-125924. 2019

A PHASE 3 STUDY OF ENASIDENIB (ENA) VERSUS CONVENTIONAL CARE REGIMENS (CCR) IN OLDER PATIENTS WITH LATE-STAGE MUTANT-IDH2 (MIDH2) RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (R/R AML)

Papayannidis, C.; (...); de Botton, S.

Meeting Abstract. 2021

A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia.

Vives S; (...); PETHEMA Group

Article. 10.1002/cncr.33403. 2021

A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients

Sanchez, MPM; (...); Montesinos, P

Article. 10.1007/s00277-021-04542-8. 2021

A phase I/II study of IMGN632, a novel CD123-targeting antibody-drug conjugate, in patients with relapsed/refractory acute myeloid leukemia, blastic plasmacytoid dendritic cell neoplasm, and other CD123-positive hematologic malignancies.

Daver, Naval Guastad; (...); Zweidler-McKay, Patrick A.

Meeting Abstract. 2020

A phase Ib/II study of the CD123-targeting antibody-drug conjugate IMGN632 as monotherapy or in combination with venetoclax and/or azacitidine for patients with CD123-positive acute myeloid leukemia.

Daver, Naval Guastad; (...); Zweidler-McKay, Patrick A.

Meeting Abstract. 2020

A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia

Martínez-Cuadrón D; (...); CETLAM and PETHEMA groups

Article. 10.1007/s00277-018-3229-5. 2018

A phase III study of venetoclax plus low-dose cytarabine in previously untreated older patients with acute myeloid leukemia (VIALE-C): A six-month update.

Wei, AH; (...); Panayiotidis, P

Meeting Abstract. 2020

A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients

Martinez-Cuadron, D; (...); Spanish PETHEMA group

Article. 10.1016/j.leukres.2018.11.006. 2019

A predictive model for prostate cancer incorporating PSA molecular forms and age.

Oto J; (...); Navarro S

Article. 10.1038/s41598-020-58836-4. 2020

A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia.

Zeidner JF; (...); Douglas Smith B

Letter. 10.1038/s41408-021-00568-3. 2021

A randomized, intraindividual, non-inferiority, Phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the treatment of actinic keratosis.

Dirschka T; (...); Puig S

Article. 10.1111/jdv.15185. 2019

A Reductive Metabolic Switch Protects Infants with Transposition of Great Arteries Undergoing Atrial Septostomy against Oxidative Stress.

Pineiro-Ramos, Jose David; (...); Vento M

Article. 10.3390/antiox10101502. 2021

A review of international clinical practice guidelines for the use of oxygen in the delivery room resuscitation of preterm infants

Wilson A; (...); Oei JL

Review. 10.1111/apa.14012. 2018

A Review of Oxygen Use During Chest Compressions in Newborns-A Meta-Analysis of Animal Data

Garcia-Hidalgo, C; (...); Schmolzer, GM

Review. 10.3389/fped.2018.00400. 2018

A review of terms used to define cutaneous squamous cell carcinoma with a poor prognosis

Canueto, J; (...); Sanmartin, O

Review. 10.1016/j.ad.2019.06.005. 2020

A Study of IMGN632, a Novel CD123-Targeting Antibody-Drug Conjugate, for Patients with Frontline and Relapsed/Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Pemmaraju, Naveen; (...); Daver, Naval

Meeting Abstract. 10.1182/blood-2021-146681. 2021

Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma

de Unamuno Bustos, B; (...); Botella Estrada, R

Article. 10.1111/bjd.16254. 2018

Accuracy of SCORTEN and ABCD-10 to predict mortality and the influence of renal function in Stevens-Johnson syndrome/toxic epidermal necrolysis

Torres-Navarro, I; (...); Botella-Estrada, R

Article. 10.1111/1346-8138.15490. 2020

Accuracy of SCORTEN to predict the prognosis of Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis

Torres-Navarro, I, Briz-Redon, A, Botella-Estrada, R

Review. 10.1111/jdv.16137. 2020

Accuracy of the fetal cerebroplacental ratio for the detection of intrapartum compromise in nonsmall fetuses().

Morales-Rosello, J; (...); Perales-Marin, A

Article. 10.1080/14767058.2018.1450380. 2019

Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols

Sitges, M; (...); Vives, S

Article. 10.1111/ejh.13417. 2020

Acute Myeloid Leukemia: Experience of a Single Center in Colombia

Sossa, C; (...); Chalela, C

Meeting Abstract. 10.1016/j.clml.2018.07.067. 2018

Acute Promyelocytic Leukemia during Pregnancy: A Systematic Review of the Literature

Santolaria, A; (...); Sanz, MA

Review. 10.3390/cancers12040968. 2020

Advanced type 1 hyperoxaluria presenting as livedo racemosa in a patient with end-stage renal disease

Torres-Navarro, I; (...); Moral-Moral, P

Letter. 10.4103/ijdvl.IJDVL_1030_18. 2019

Advances in the management of coagulopathy in acute promyelocytic leukemia

Sanz MA, Montesinos P

Article. 10.1016/S0049-3848(20)30399-6. 2020

Adverse prognostic impact of complex karyotype (>= 3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL)

Genesca, E; (...); Ribera, JM

Article. 10.1016/j.leukres.2021.106612. 2021

AGILE: A Global, Randomized, Double-Blind, Phase 3 Study of Ivosidenib plus Azacitidine Versus Placebo plus Azacitidine in Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation

Montesinos, Pau; (...); Doehner, Hartmut

Meeting Abstract. 10.1182/blood-2021-147805. 2021

AGILE: A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Ivosidenib in Combination with Azacitidine in Adult Patients with Previously Untreated Acute Myeloid Leukemia with an IDH1 Mutation

Montesinos Fernandez, Pau; (...); Paschka, Peter

Meeting Abstract. 10.1182/blood-2019-123045. 2019

Allogeneic Hematopoietic Stem Cell Transplantation Following the Use of Hypomethylating Agents among Patients with Relapsed or Refractory AML: Findings from an International Retrospective Study

Stahl, M; (...); Zeidan, AM

Article. 10.1016/j.bbmt.2018.03.025. 2018

An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens

Sobas, M; (...); GATLA Cooperative Grp

Article. 10.1080/10428194.2018.1516875. 2019

An antisaccade task for measuring the attentional characteristics of social information processing in children with autism spectrum conditions

Lizaran, M; (...); Garcia-Blanco, A

Meeting Abstract. 10.1192/j.eurpsy.2021.606. 2021

An eye-tracking study for measuring the attentional characteristics towards emotional scenes in children with autism spectrum condition

Lizaran, M; (...); Garcia-Blanco, A

Meeting Abstract. 10.1192/j.eurpsy.2021.605. 2021

Analysis of Lipid Peroxidation by UPLC-MS/MS and Retinoprotective Effects of the Natural Polyphenol Pterostilbene.

Torres-Cuevas I; (...); Ortega ÁL

Article. 10.3390/antiox10020168. 2021

Analysis of SNP Array Abnormalities in Patients with DE NOVO Acute Myeloid Leukemia with Normal Karyotype

Ibanez, M; (...); Cervera, J

Article. 10.1038/s41598-020-61589-9. 2020

Analysis of three salvage treatment regimens after relapsed/refractory acute myeloi leukemia (AML) (FLAG-Ida, FLAGO-IDA and PLERIFLAG)

Bergua, J; (...); Montesinos, P

Meeting Abstract. 2018

Anti-D Alloimmunization after RhD-Positive Platelet Transfusion in RhD-Negative Women under 55 Years Diagnosed with Acute Leukemia: Results of a Retrospective Study

Villalba, A; (...); Solves, P

Article. 10.1159/000488804. 2018

Antiepileptic drug reduction and increased risk of stimulation-evoked focal to bilateral tonic-clonic seizure during cortical stimulation in patients with focal epilepsy

Hampel, Kevin G.; (...); Villanueva, Vicente

Article. 10.1016/j.yebeh.2017.12.033. 2018

Anxiety and depressive symptoms, and stress biomarkers in pregnant women after in vitro fertilization: a prospective cohort study

Garcia-Blanco, A; (...); Chafer-Pericas, C

Article. 10.1093/humrep/dey109. 2018

APPLICATION OF THE MASS SEQUENCING FOR THE STUDY OF MUTATIONS, REORDERINGS AND CHANGES IN GENE EXPRESSION IN THE HEMATOLOGICAL MYELOID NEOPLASIAS

Simarro, CS; (...); Gonzalez, EB

Meeting Abstract. 2018

APPROACH TO THE STUDY OF THE ALTERATIONS OF METABOLISM IN THE LMA

Simarro, CS; (...); Gonzalez, EB

Meeting Abstract. 2018

Assessment of Acute Acral Lesions in a Case Series of Children and Adolescents During the COVID-19 Pandemic

Roca-Gines, J; (...); Evole-Buselli, M

Article. 10.1001/jamadermatol.2020.2340. 2020

Assessment of lipid peroxidation and artificial neural network models in early Alzheimer Disease diagnosis.

Article. 10.1016/j.clinbiochem.2019.07.008. 2019

ATR-FTIR spectroscopy for the routine quality control of exosome isolations

Ramos-Garcia, V; (...); Kuligowski, J

Article. 10.1016/j.chemolab.2021.104401. 2021

Attentional biases towards emotional scenes in autism spectrum condition: An eye-tracking study.

Sahuquillo-Leal, Rosa; (...); Garcia-Blanco, Ana

Article. 10.1016/j.ridd.2021.104124. 2022

Attentional Patterns to Emotional Faces Versus Scenes in Children with Autism Spectrum Disorders

Ghosn, F; (...); Garcia-Blanco, A

Article. 10.1007/s10803-018-3847-8. 2019

Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy.

Wei, AH; (...); DiNardo, CD

Article. 10.1038/s41408-021-00565-6. 2021

AUTOANTIBODY PROFILE ANALYSIS AND ITS ASSOCIATION WITH CLINICAL MANIFESTATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

Garcia, EG; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.5699. 2019

Azacitidine or Decitabine Monotherapy for the Treatment of AML: A Comparative Systematic Review and Meta-Analysis

Saiz-Rodriguez, M; (...); Montesinos, P

Meeting Abstract. 2021

AZACITIDINE VS. DECITABIN IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RE-DIAGNOSED: RESULTS OF THE PETHEMA AML REGISTER

Jorge, Labrador; (...); Pau, Montesinos

Meeting Abstract. 2021

Biomarkers of oxidative stress derived damage to proteins and DNA in human breast milk

Sanchez-Illana, A; (...); Kuligowski, J

Article. 10.1016/j.aca.2018.01.054. 2018

Biomonitoring of bisphenols A, F, S and parabens in urine of breastfeeding mothers: Exposure and risk assessment

Sanchis, Y; (...); Yusa, V

Article. 10.1016/j.envres.2020.109481. 2020

Biomonitoring of bisphenols A, F, Sin human milk and probabilistic risk assessment for breastfed infants

Dualde, P; (...); Yusa, V

Article. 10.1016/j.scitotenv.2019.03.024. 2019

Biomonitoring of non-persistent pesticides in urine from lactating mothers: Exposure and risk assessment.

Fernández SF; (...); Yusà V

Article. 10.1016/j.scitotenv.2019.134385. 2020

Biomonitoring of parabens in human milk and estimated daily intake for breastfed infants.

Dualde, P; (...); Yusa, V

Article. 10.1016/j.chemosphere.2019.124829. 2020

Biomonitoring of polychlorinated dibenzo-p-dioxins (PCDDs), polychlorinated dibenzofurans (PCDFs) and dioxin-like polychlorinated biphenyls (dl-PCBs) in human milk: Exposure and risk assessment for lactating mothers and breastfed children from Spain

Hernandez, CS; (...); BETTERMILK

Article. 10.1016/j.scitotenv.2020.140710. 2020

Brain signal intensity changes as biomarkers in amyotrophic lateral sclerosis

Vazquez-Costa, JF; (...); Sevilla, T

Article. 10.1111/ane.12863. 2018

Can stress predict delivery date?: Role of chronic and acute stress to the threatened preterm labor as predictors of delivery date

Lorenzo, JB; (...); Gonzalez, PS

Meeting Abstract. 10.1192/j.eurpsy.2021.1619. 2021

Cardiovascular risk reduction over time in patients with diabetes or pre-diabetes undergoing bariatric surgery: data from a single-center retrospective observational study

Rubio-Almanza, M; (...); Merino-Torres, JF

Article. 10.1186/s12902-018-0317-4. 2018

Circulating miRNAs as diagnostic biomarkers for adolescent idiopathic scoliosis

Garcia-Gimenez, JL; (...); Bas, T

Article. 10.1038/s41598-018-21146-x. 2018

Clinical and immunological aspects of microRNAs in neonatal sepsis.

Fatmi, Ahlam; (...); Garcia-Gimenez, Jose Luis

Article. 10.1016/j.biopha.2021.112444. 2022

Clinical Benefit of Glasdegib Plus Low-Dose Cytarabine in Patients with De Novo and Secondary Acute Myeloid Leukemia: Long-Term Analysis of a Phase 2 Randomized Trial

Heuser, M; (...); Cortes, JE

Meeting Abstract. 10.1016/j.clml.2019.07.116. 2019

Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial (vol 100, pg 1181, 2021)

Heuser, Michael; (...); Cortes, Jorge E.

Article. 10.1007/s00277-021-04545-5. 2021

Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial.

Heuser M; (...); Cortes JE

Article. 10.1007/s00277-021-04465-4. 2021

Clinical Management of Cutaneous Adverse Events in Patients on Chemotherapy: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology

Sanmartin, O; (...); Gravalos, C

Article. 10.1016/j.ad.2019.01.011. 2019

Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology

Gravalos, C; (...); Botella, R

Article. 10.1007/s12094-018-1953-x. 2019

Clinical Outcomes in Patients with Relapsed/Refractory Acute Myeloid Leukemia Treated with Gilteritinib Who Received Prior Midostaurin or Sorafenib

Perl, AE; (...); Tiu, RV

Meeting Abstract. 2021

Clinical Practice Guideline on Melanoma From the Spanish Academy of Dermatology and Venereology (AEDV).

Botella-Estrada R; (...); García-Doval I

Article. 10.1016/j.ad.2020.07.003. 2021

Clinical Profile of IMGN632, a Novel CD123-Targeting Antibody-Drug Conjugate (ADC), in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Daver, Naval G.; (...); Kantarjian, Hagop M.

Meeting Abstract. 10.1182/blood-2019-128648. 2019

Clinical significance of complex karyotype at diagnosis in pediatric and adult patients with de novo acute promyelocytic leukemia treated with ATRA and chemotherapy

Labrador, J; (...); GATLA Grp

Article. 10.1080/10428194.2018.1522438. 2019

Clinical usefulness of the non-invasive functional study of the lower urinary tract voiding phase as a predictor of resolution after the first endoscopic treatment of vesico-ureteral reflux in children older than 3 years

Varch-Villalba, JA; (...); Tormo, FB

Article. 2019

Clinical Utility of a Next-Generation Sequencing Panel for Acute Myeloid Leukemia Diagnostics

Alonso, CM; (...); Barragan, E

Article. 10.1016/j.jmoldx.2018.09.009. 2019

Clinical Utility of Plasma Lipid Peroxidation Biomarkers in Alzheimer's Disease Differential Diagnosis

Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo

Article. 10.3390/antiox9080649. 2020

Clinician Concepts of Cure in Adult Relapsed and Refractory Philadelphia-Negative B Cell Precursor Acute Lymphoblastic Leukemia: A Delphi Study

Bassan, R; (...); Cong, Z

Article. 10.1007/s12325-019-00910-z. 2019

Clonal genetic evolution at relapse of favorable-risk acute myeloid leukemia with NPM1 mutation is associated with phenotypic changes and worse outcomes

Martinez-Losada, C; (...); Sanchez-Garcia, J

Letter. 10.3324/haematol.2018.188433. 2018

Cohort study showed that growth rate increment has not been enough to prevent growth retardation of preterm infants and raised concerns about unbalanced growth.

Zozaya, C; (...); Saenz de Pipaón M

Article. 10.1111/apa.14819. 2019

Cohort-Controlled Comparison of Umbilical Cord Blood Transplantation Using Carlecortemcel-L, a Single Progenitor-Enriched Cord Blood, to Double Cord Blood Unit Transplantation

Stiff, PJ; (...); Sanz, G

Article. 10.1016/j.bbmt.2018.02.012. 2018

Coma blisters. A key to neurological diagnosis.

Letter. 10.1016/j.nrl.2018.11.005. 2020

Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis.

Gil-Perotin S; (...); Casanova B

Article. 10.3389/fneur.2019.01008. 2019

Comment on 'Two cases of COVID-19 presenting with a clinical picture resembling chilblains: first report from the Middle East': pernio unrelated to COVID-19

Torres-Navarro, I; (...); Evole-Buselli, M

Letter. 10.1111/ced.14255. 2020

Comparing Targeted vs. Untargeted MS2 Data-Dependent Acquisition for Peak Annotation in LC-MS Metabolomics

Ten-Domenech, I; (...); Kuligowski, J

Article. 10.3390/metabo10040126. 2020

COMPARISON OF AZACITIDINE AND DECITABINE FOR THE TREATMENT OF NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: SYSTEMATIC REVIEW AND META-ANALYSIS

Saiz-Rodriguez, M.; (...); Labrador, J.

Meeting Abstract. 2020

Comparison of intensive, pediatric-inspired therapy with non-intensive therapy in older adults aged 55-65 years with Philadelphia chromosome-negative acute lymphoblastic leukemia

Ribera, JM; (...); PETHEMA Grp

Article. 10.1016/j.leukres.2018.03.010. 2018

Comparison of six different methods to calculate cell densities

Camacho-Fernadez, C; (...); Segui-Simarro, JM

Article. 10.1186/s13007-018-0297-4. 2018

Comparison of transfusion requirements in adult patients undergoing Haploidentical or single-unit umbilical cord blood stem cell transplantation

Solves, P; (...); Sanz, GF

Article. 10.1111/ejh.13270. 2019

Complete response of a locally advanced basosquamous carcinoma with vismodegib treatment

Letter. 10.4103/ijdvl.IJDVL_647_18. 2019

Complex Karyotype with >= 3 Cytogenetic Alterations is a New Marker of Worse Prognosis in Adult T-Cell Acute Lymphoblastic Leukemia (T-ALL)

Genesca, Eulalia; (...); Maria Ribera, Josep

Meeting Abstract. 2020

Complications Associated with Mohs Micrographic Surgery: Data from the Nationwide Prospective Cohort REGESMOHS

Ruiz-Salas, Veronica; (...); Garcia-Doval, Ignacio

Article. 10.1159/000517010. 2021

Computed tomography at C3 level and dynamometry as techniques for the diagnosis of sarcopenia in head and neck cancer patients

Muresan, BT; (...); Lopez-Torrecilla, J

Article. 10.14306/renhyd.24.2.927. 2020

Congenital Critical Heart Defect Screening in a Health Area of the Community of Valencia (Spain): A Prospective Observational Study

Cubells, E; (...); Vento, M

Article. 10.3390/ijns4010003. 2018

Correction to: A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.

Martínez-Cuadrón D; (...); CETLAM and PETHEMA groups

Article. 10.1007/s00277-018-3277-x. 2018

Correction to: Update on management and progress of novel therapeutics for R/R AML: an Iberian expert panel consensus.

Montesinos P; (...); Sanz MÁ

Correction. 10.1007/s00277-020-03933-7. 2020

Correction: Nitric oxide and preterm resuscitation: some words of caution.

Vento M, Sánchez-Illana Á

Correction. 10.1038/s41390-020-0746-4. 2020

CORRELATION BETWEEN PATIENT-REPORTED OUTCOMES OF HEALTH-RELATED QUALITY OF LIFE AND CLINICAL ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

Garcia, EG; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.5661. 2019

Corrigendum to "Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study" [Leuk. Res. 92 (March) (2020) 106352].

Rodríguez-Medina C; (...); Montesinos P

Correction. 10.1016/j.leukres.2020.106388. 2020

Corrigendum to "Relationship between structural damage with loss of strength and functional disability in psoriatic arthritis patients" [Clin. Biomech. volume 68 (2019) Pages 169-174/Article Number JCLB 4795].

Olmos CMF; (...); Ivorra JAR

Correction. 10.1016/j.clinbiomech.2019.10.023. 2020

Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain

Mareque, M; (...); Sierra, J

Article. 10.2147/CEOR.S302097. 2021

COST-EFFECTIVENESS OF GEMTUZUMAB OZOGAMICIN IN COMBINATION WITH STANDARD CHEMOTHERAPY IN FIRST-LINE TREATMENT IN PATIENTS WITH CD-33-POSITIVE ACUTE MYELOID LEUKEMIA IN SPAIN

Montesinos, P.; (...); Guinea, J. M.

Meeting Abstract. 2020

Cost-Effectiveness Of Midostaurin In The Treatment Of Acute Myeloid Leukemia With The FLT3 Mutation In Spain

Arenaza, A; (...); Vinent, JL

Article. 10.2147/CEOR.S222879. 2019

Cribado de cardiopatias congenitas criticas en el periodo neonatal. Recomendacion de la Sociedad Espanola de Neonatologia.

Sánchez Luna M; (...); Rite Gracia S

Abstract of Published Item. 10.1016/j.anpedi.2017.06.011. 2018

Cumulative life stressors and stress response to threatened preterm labour as birth date predictors

Campos-Berga, Laura; (...); Garcia-Blanco, Ana

Article. 10.1007/s00404-021-06251-z. 2021

Current Practice in Untargeted Human Milk Metabolomics.

Ten-Doménech I; (...); Quintás G

Review. 10.3390/metabo10020043. 2020

CURRENT STATE OF ACUTE MYELOID LEUKEMIA IN SPAIN: RESULTS FROM A DELPHI STUDY ON EPIDEMIOLOGY, DISEASE MANAGEMENT AND UNMET NEEDS

Montesinos, P; (...); Sierra, J

Meeting Abstract. 2018

Current status of acute myeloid leukaemia in Spain: Results from a Delphi study on its epidemiology, disease management and unmet clinical needs.

Montesinos P, Gil A, Sierra J

Letter. 10.1016/j.medcli.2020.04.032. 2020

Cutaneous and mucocutaneous leishmaniasis: experience of a Mediterranean hospital.

Garrido-Jareño M; (...); Pemán-García J

Article. 10.1186/s13071-020-3901-1. 2020

Challenges in the diagnosis and treatment of secondary acute myeloid leukemia

Ossenkoppele, G, Montesinos, P

Review. 10.1016/j.critrevonc.2019.03.003. 2019

Changing Trends in Drug Prescription and Causes of Treatment Discontinuation of First Biologic Over Ten Years in Psoriasis in the Spanish Biobadaderm Registry.

Ruiz-Genao DP; (...); García-Doval I

Article. 10.1016/j.ad.2020.05.008. 2020

Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants.

Cicconi, L; (...); Abla, O

Article. 10.1038/s41408-021-00561-w. 2021

Characteristics and outcome of adult patients with acute promyelocytic leukemia and increased body mass index treated with the PETHEMA Protocols.

Sobas M; (...); PETHEMA, HOVON, PALG, GATLA cooperative groups

Article. 10.1111/ejh.13346. 2020

Characteristics and Outcome of Early T Cell Precursor ALL (ETP-ALL) Patients Treated with High-Risk Spanish Pethema Protocols

Genesca, E; (...); Ribera, JM

Meeting Abstract. 10.1182/blood-2018-99-114559. 2018

Characteristics and Outcome of Older Patients with Acute Promyelocytic Leukemia Front-Line Treated with or without Arsenic Trioxide - an International Collaborative Study

Kayser, S; (...); Montesinos, P

Meeting Abstract. 10.1182/blood-2018-99-111768. 2018

Characteristics and Outcome of Patients with Acute Myeloid Leukemia and Trisomy 4

Kayser, Sabine; (...); Schlenk, Richard F.

Meeting Abstract. 10.1182/blood-2021-150281. 2021

Characteristics and outcome of patients with core binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative study.

Kayser S; (...); Levis MJ

Article. 10.3324/haematol.2021.278645. 2022

Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group

Palanques-Pastor, Tomas; (...); Montesinos, Pau

Article. 10.1080/10428194.2021.1948031. 2021

Characteristics, Treatment Patterns and Outcomes Among Newly Diagnosed Patients (pts) with Acute Myeloid Leukemia (AML) Who Present with Hyperleukocytosis: Findings from a Large International Patient Cohort

Stahl, M; (...); Zeidan, AM

Meeting Abstract. 10.1182/blood-2018-99-112974. 2018

CHARACTERIZATION OF THE GENOMIC AND TRANSCRIPTOMIC PROFILE OF THE ACUTE MYELOID LEUKEMIA (AML) SUBGROUP "CHROMATIN-SPLICEOSOME"

Alessandro, Liquori; (...); Zamora Jose, Cervera

Meeting Abstract. 2020

Characterization of thrombosis risk in patients with cancer

Cerezuela, P; (...); Trujillo-Santos, J

Meeting Abstract. 10.1016/j.thromres.2018.02.121. 2018

Chemotherapy or Allogeneic Transplantation in High-Risk Philadelphia Chromosome-Negative Adult Lymphoblastic Leukemia.

Ribera JM; (...); Orfao A

Article. 10.1182/blood.2020007311. 2020

Chromosomal Abnormalities and Prognosis in NPM1 -Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts.

Angenendt, L; (...); Schliemann, C

Article. 10.1200/JCO.19.00416. 2019

Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review

Megias-Vericat, JE; (...); Montesinos, P

Review. 10.1080/17512433.2019.1573668. 2019

Decitabine as Salvage Therapy after Azacitidine in AML

De La Fuente, A; (...); Montesinos, P

Meeting Abstract. 2019

Delayed vs Immediate Cord Clamping Changes Oxygen Saturation and Heart Rate Patterns in the First Minutes after Birth.

Padilla-Sánchez C; (...); Vento M

Article. 10.1016/j.jpeds.2020.07.045. 2020

Dermatomyositis panniculitis: A case series and review of the literature

Calle, A; (...); Santos-Briz, A

Meeting Abstract. 2018

Development and electronic validation of the revised Cystic Fibrosis Questionnaire (CFQ-R Teen/Adult) New tool for monitoring psychosocial health in CF

Sole, Amparo; (...); Quittner, Alexandra L.

Article. 10.1016/j.jcf.2017.10.015. 2018

DHA reduces oxidative stress following hypoxia-ischemia in newborn piglets: a study of lipid peroxidation products in urine and plasma

Huun, MU; (...); Solberg, R

Article. 10.1515/jpm-2016-0334. 2018

Diagnosis of Lung Cancer Due to a Complicated Abscess.

Torres-Navarro I, Piqueras-García J, Botella-Estrada R

Editorial Material. 10.1016/j.ad.2018.01.020. 2019

DIFFERENCES IN BONE METABOLISM BETWEEN INTERMITTENT AND CONTINUOUS TREATMENT WITH LHRH AGONISTS IN PROSTATE CANCER PATIENTS

Arevalo, KR; (...); Roman, JA

Meeting Abstract. 10.1136/annrheumdis-2018-eular.6948. 2018

Differences in ex-vivo Chemosensitivity to Anthracyclines in First Line Acute Myeloid Leukemia

Megias-Vericat, JE; (...); Spanish PETHEMA Grp

Article. 10.4084/MJHID.2019.016. 2019

Different clinical response to interferon beta and glatiramer acetate related to the presence of oligoclonal IgM bands in CSF in multiple sclerosis patients

Casanova, B; (...); Coret, F

Article. 10.1007/s10072-018-3442-y. 2018

Differential cytokine profiles and drop of faecal calprotectin for prediction of primary response to infliximab induction therapy in Crohn's disease

Mateos, B; (...); Beltran, B

Meeting Abstract. 10.1093/ecco-jcc/jjy222.725. 2019

Differential expression of miRNAs present in plasma and contained within circulating microparticles in precapillary pulmonary hypertension

Oto, Julia; (...); Albert Barbera, Joan

Meeting Abstract. 10.1183/13993003.congress-2019.PA5050. 2019

Differentiation Syndrome with Lower-intensity Treatments for Acute Myeloid Leukemia.

Fathi, Amir T; (...); de Botton, Stephane

Review. 10.1002/ajh.26142. 2021

Divided or kissing nevus of the penis: A new case with dermoscopic findings

Armengot-Carbo, M, Rodrigo-Nicolas, B, Botella-Estrada, R

Article. 10.1111/pde.13556. 2018

DNA Copy Number Variation Associated with Anti-tumour Necrosis Factor Drug Response and Paradoxical Psoriasiform Reactions in Patients with Moderate-to-severe Psoriasis

Sanz-Garcia, A; (...); Ovejero-Benito, MC

Article. 10.2340/00015555-3794. 2021

DNA Methylation Analysis to Unravel Altered Genetic Pathways Underlying Early Onset and Late Onset Neonatal Sepsis. A Pilot Study.

Lorente-Pozo S; (...); García-Giménez JL

Article. 10.3389/fimmu.2021.622599. 2021

DNA methylation signatures associated with pathogenesis Crohn's disease-related genes

Tatay, IM; (...); Beltran, B

Meeting Abstract. 2019

Do children with overweight respond faster to food-related words?

Tarrega, Josefina; (...); Garcia-Blanco, Ana

Article. 10.1016/j.appet.2021.105134. 2021

Do levels of lipid peroxidation biomarkers reflect the degree of brain injury in newborns?

Cascant-Vilaplana, Mari Merce; (...); Vento, Maximo

Article. 10.1089/ars.2021.0168. 2021

Does maternal age or related factors influence the appearance of psychopathology in children?

Lorenzo, JB; (...); Vento, M

Meeting Abstract. 10.1192/j.eurpsy.2021.400. 2021

Does Metabolic Surgery Lead to Diabetes Remission in Patients with BMI < 30 kg/m(2)?: a Meta-analysis

Rubio-Almanza, Matilde; (...); Merino-Torres, JF

Article. 10.1007/s11695-018-03654-x. 2019

Does Pasteurized Donor Human Milk Efficiently Protect Preterm Infants Against Oxidative Stress?

Parra-Llorca, A; (...); Vento, M

Article. 10.1089/ars.2019.7821. 2019

Drug-drug interactions of newly approved small molecule inhibitors for acute myeloid leukemia

Sahuquillo-Torralba, A, Rodriguez-Serna, M, Botella Estrada R

Review. 10.1007/s00277-020-04186-0. 2020

Early neurotransmission impairment in non-invasive Alzheimer Disease detection

Pena-Bautista, Carmen; (...); Cháfer-Pericás C

Article. 10.1038/s41598-020-73362-z. 2020

Early Referral to an ALS Center Reduces Several Months the Diagnostic Delay: A Multicenter-Based Study.

Martínez-Molina M; (...); Vázquez-Costa JF

Article. 10.3389/fneur.2020.604922. 2020

Early signs of autism in infants whose mothers suffered from a threatened preterm labour: a 30-month prospective follow-up study.

Ghosn F; (...); García-Blanco A

Article. 10.1007/s00787-021-01749-y. 2021

Efecto de la adición de fortificantes y de módulo de proteínas en la osmolalidad de la leche materna donada.

Torres Martínez E; (...); Vento M

Article. 10.1016/j.anpedi.2020.03.009. 2020

Effect of a Marathon on Skin Temperature Response After a Cold-Stress Test and Its Relationship With Perceptive, Performance, and Oxidative-Stress Biomarkers

Priego-Quesada, JI; (...); Palmer, RS

Article. 10.1123/ijspp.2019-0963. 2020

Effect of allopurinol in addition to hypothermia treatment in neonates for hypoxic-ischemic brain injury on neurocognitive outcome (ALBINO): study protocol of a blinded randomized placebo-controlled parallel group multicenter trial for superiority (phase III)

Benders, MJNL; (...); ALBINO Study Grp

Article. 10.1186/s12887-019-1566-8. 2019

Effect of donor human milk on host-gut microbiota and metabolic interactions in preterm infants.

Piñeiro-Ramos JD; (...); Vento M

Article. 10.1016/j.clnu.2020.08.013. 2020

Effect of enasidenib (ENA) plus azacitidine (AZA) on complete remission and overall response versus AZA monotherapy in mutant-IDH2 (mIDH2) newly diagnosed acute myeloid leukemia (ND-AML).

Dinardo, CD; (...); Dohner, H

Meeting Abstract. 2020

Effect of gilteritinib on survival in patients with FLT3-mutated (FLT3(mut+)) relapsed/refractory (RR) AML who have common AML co-mutations or a high FLT3-ITD allelic ratio.

Levis, MJ; (...); Bahceci, E

Meeting Abstract. 2019

EFFECT OF MISSENSE MUTATIONS IN THE SPLICING OF PATIENTS WITH ACUTE MYELOID LEUKAEMIA

Morote-Faubel, M.; (...); Cervera, J.

Meeting Abstract. 2019

Effect of olutasidenib (FT-2102) on complete remissions in patients with relapsed/refractory (R/R) mIDH1 acute myeloid leukemia (AML): Results from a planned interim analysis of a phase 2 clinical trial.

De Botton, Stephane; (...); Fenaux, Pierre

Meeting Abstract. 10.1200/JCO.2021.39.15_suppl.7006. 2021

Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort

Hernandez-Fernandez, CP; (...); Garcia-Doval, I

Article. 10.2340/00015555-3711. 2021

Effect of uric acid in animal models of ischaemic stroke: A systematic review and meta-analysis.

Aliena-Valero A; (...); Salom JB

Review. 10.1177/0271678X20967459. 2021

EFFECTIVENESS AND TOXICITY OF THE USE OF INOTUZUMAB (INO) IN PATIENTS WITH RESISTANT OR RECALLING (R/R) ACUTE LYMPHOBLASTIC LEUKEMIA (LAL). STUDY OF PATIENTS INCLUDED IN INO'S EXPANDED USE PROGRAM

Ribera Santasusana, J. M.; (...); Valero, M.

Meeting Abstract. 2021

Effectiveness in the treatment of solar urticaria with omalizumab: Report of 7 cases

Letter. 10.1016/j.medcli.2018.01.003. 2018

Efficacy and safety of native versus pegylated Escherichia coli asparaginase for treatment of adults with high-risk, Philadelphia chromosome-negative acute lymphoblastic leukemia

Ribera, JM; (...); PETHEMA Group, Spanish Society of Hematology

Article. 10.1080/10428194.2017.1397661. 2018

Efficacy and Safety of Single-Agent Quizartinib (Q), a Potent and Selective FLT3 Inhibitor (FLT3i), in Patients (pts) with FLT3-Internal Tandem Duplication (FLT3-ITD)-Mutated Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) Enrolled in the Global, Phase 3, Randomized Controlled Quantum-R Trial

Cortes, JE; (...); Levis, MJ

Meeting Abstract. 10.1182/blood-2018-99-110439. 2018

Efficacy and Safety of Single-Agent Quizartinib (Q), Potent and SeleEfficacy and Safety of Single-Agent Quizartinib (Q), a Potent and Selective FLT3 Inhibitor (FLT3i), in Patients (pts) with FLT3-Internal Tandem Duplication (FLT3-ITD)-Mutated Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) Enrolled in the Global, Phase 3, Randomized Controlled QuANTUM-R Trial

Cortes, JE; (...); Levis, MJ

Meeting Abstract. 2019

Efficacy and Safety of Single-Agent Quizartinib, a Potent and Selective FLT3 Inhibitor (FLT3i), in Patients (pts) With FLT3-Internal Tandem Duplication (FLT3-ITD) - Mutated Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) Enrolled in the Global, Phase 3, Randomized Controlled QuANTUM-R Trial

Jonas, BA; (...); Levis, MJ

Meeting Abstract. 10.1016/j.clml.2019.07.097. 2019

Efficacy Study of Anti-Endomysium Antibodies for Celiac Disease Diagnosis: A Retrospective Study in a Spanish Pediatric Population.

Roca M; (...); Ribes-Koninckx C

Article. 10.3390/jcm8122179. 2019

Emergent Uric Acid Treatment is Synergistic with Mechanical Recanalization in Improving Stroke Outcomes in Male and Female Rats

Aliena-Valero, A; (...); Salom, JB

Article. 10.1016/j.neuroscience.2018.07.045. 2018

Emerging Mutations at Relapse in Patients with FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia Who Received Gilteritinib Therapy in the Phase 3 Admiral Trial.

Smith CC; (...); Bahceci E

Article. 10.1182/blood-2019-122620. 2019

Emotional regulation and psychomotor development after threatening preterm labor: a prospective study.

Campos-Berga L; (...); García-Blanco A

Article. 10.1007/s00787-021-01733-6. 2021

Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial.

DiNardo CD; (...); Döhner H

Article. 10.1016/S1470-2045(21)00494-0. 2021

Environmental Exposure during Pregnancy: Influence on Prenatal Development and Early Life: A Comprehensive Review.

Gómez-Roig MD; (...); Vento M

Review. 10.1159/000514884. 2021

Equity in coronavirus disease 2019 vaccine development and deployment.

Modi N; (...); Voto L

Article. 10.1016/j.ajog.2021.01.006. 2021

Erfolgreiche Imatinib-Therapie einer mit dem myeloproliferativen hypereosinophilen Syndrom mit PDGFRA-Rearrangement assoziierten lymphomatoiden Papulose

Letter. 10.1111/ddg.14064_g. 2020

Escalated dosing schedules of CC-486 for patients experiencing first acute myeloid leukemia (AML) relapse: Results from the phase III QUAZAR AML-001 maintenance trial.

Dohner, H; (...); Roboz, GJ

Meeting Abstract. 2020

European Consensus Guidelines on the Management of Respiratory Distress Syndrome-2019 Update

Sweet, David G.; (...); Halliday, Henry L.

Article. 10.1159/000499361. 2019

Evaluation of batch effect elimination using quality control replicates in LC-MS metabolite profiling

Sanchez-Illana, Angel; (...); Kuligowski, Julia

Article. 10.1016/j.aca.2018.02.053. 2018

Evidence for shared environmental contributions to attention-deficit/hyperactivity traits. A twin study

Iranzo-Tatay, C; (...); Bofill, I

Article. 10.1016/j.ejpsy.2019.04.002. 2019

Evolving patterns of care and outcomes in relapsed/refractory FLT3 mutated acute myeloid leukemia adult patients.

Boluda B; (...); Montesinos P

Article. 10.1080/10428194.2021.1938031. 2021

Evolving treatment patterns and outcomes in older patients (=60 years) with AML: changing everything to change nothing?

Martínez-Cuadrón D; (...); Montesinos P

Article. 10.1038/s41375-020-01058-4. 2020

Experience with IMGN632, a Novel CD123-Targeting Antibody-Drug Conjugate (ADC), in Frontline Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Pemmaraju, Naveen; (...); Daver, Naval

Meeting Abstract. 10.1182/blood-2021-146666. 2021

Experimental support for multidrug resistance transfer potential in the preterm infant gut microbiota.

Hagbø M; (...); Rudi K

Article. 10.1038/s41390-019-0491-8. 2020

Exposure and Risk Assessment of Hg, Cd, As, Tl, Se, and Mo in Women of Reproductive Age Using Urinary Biomonitoring.

Coscollà C; (...); Yusà V

Article. 10.1002/etc.4996. 2021

Extracorporeal photopheresis vs standard therapies for steroid-refractory chronic graft-vs-host disease: Pharmacoeconomic assessment of hospital resource use in Spain.

Boluda, Blanca; (...); Montesinos, Pau

Article. 10.1002/jca.21901. 2021

Factors Associated with Survival and Survival without Major Morbidity in Very Preterm Infants in Two Neonatal Networks: SEN1500 and NEOCOSUR.

García-Muñoz Rodrigo F; (...); Vento M

Article. 10.1159/000513079. 2021

Factors influencing platelet transfusion refractoriness in patients undergoing allogeneic hematopoietic stem cell transplantation

Solves P; (...); Carpio N

Article. 10.1007/s00277-017-3168-6. 2018

Faecal calprotectin and plasma cytokines in the prediction of early postoperative Crohn's disease recurrence

Cerrillo, E; (...); Beltran, B

Meeting Abstract. 2018

Family Rooms in Neonatal Intensive Care Units and Neonatal Outcomes: An International Survey and Linked Cohort Study.

Lehtonen L; (...); International Network for Evaluating Outcomes of Neonates (iNeo)

Article. 10.1016/j.jpeds.2020.06.009. 2020

Fecal calprotectin in healthy children aged 4-16 years.

Roca M; (...); Ribes-Koninckx C

Article. 10.1038/s41598-020-77625-7. 2020

FINAL RESULTS OF THE LAL-RI 08 PROTOCOL FOR ADOLESCENTS AND YOUNG ADULTS (AAJ) WITH LYMPHOBLASTIC ACUTE LEUKEMIA (LAL) OF STANDARD RISK (RE)

Santasusana, JMR; (...); Vale, AODCE

Meeting Abstract. 2018

First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia.

Salamero, Olga; (...); Somervaille TCP

Article. 10.1200/JCO.19.03250. 2020

Five-minute Apgar score and outcomes in neonates of 24-28 weeks' gestation.

Shah PS; (...); International Network for Evaluating Outcomes of Neonates (iNeo) Investigators

Article. 10.1136/archdischild-2021-322230. 2022

Focal Adhesion Genes Refine the Intermediate-Risk Cytogenetic Classification of Acute Myeloid Leukemia

Pallarès V; (...); Casanova, I

Article. 10.3390/cancers10110436. 2018

Folliculitis Decalvans Caused by Bacterial Superinfection Secondary to Erlotinib.

Letter. 10.1016/j.ad.2017.02.032. 2018

Folliculotropic Mycosis Fungoides With Flexural Eruptive Cysts and Comedones in a 14-Year-Old Boy.

Roca-Gines, J; (...); Botella-Estrada, R

Article. 10.1097/DAD.0000000000001958. 2021

Follow-up of patients with FLT3-mutated R/R AML in the phase 3 ADMIRAL trial.

Perl, Alexander E.; (...); Levis, Mark J.

Meeting Abstract. 10.1200/JCO.2021.39.15_suppl.7013. 2021

Free radical damage can cause serious long-lasting effects

Vali, P; (...); Lakshminrusimha, S

Article. 10.1111/apa.14543. 2018

Free radicals in Alzheimer's disease: Lipid peroxidation biomarkers

Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo

Review. 10.1016/j.cca.2019.01.021. 2019

Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia

Genesca, E; (...); Ribera, JM

Article. 10.1186/s13045-018-0639-8. 2018

Frequency and prognostic significance of additional cytogenetic abnormalities to the Philadelphia chromosome in young and older adults with acute lymphoblastic leukemia

Motllo C; (...); PETHEMA Group, Spanish Society of Hematology

Article. 10.1080/10428194.2017.1326596. 2018

Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain.

Ribera, Josep-Maria; (...); Pinana, Jose-Luis

Article. 10.1016/j.clml.2021.06.024. 2021

FT-2102, an IDH1m Inhibitor, in Combination with Azacitidine in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Ayndrome (MDS): Results from a Phase 1 Study

Cortes, JE; (...); Baer, MR

Meeting Abstract. 10.1182/blood-2018-99-114126. 2018

FUNCTIONAL CLASSIFICATION OF DEEP INTRONIC VARIANTS IN PATIENTS WITH ACUTE MYELOBLASTIC LEUKEMIA

Liquori, A.; (...); Cervera Zamora, J.

Meeting Abstract. 2019

FUNCTIONAL RECLASSIFICATION THROUGH MINIGENE TESTS OF MISSENSE VARIANTS WITH EFFECT ON SPLICING IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

Morote-Faubel, Mireya; (...); Cervera, Jose

Meeting Abstract. 2020

Gastrointestinal Events and Management Strategies for Patients with Acute Myeloid Leukemia (AML) in First Remission Receiving CC-486 Maintenance Therapy in the Randomized, Placebo-Controlled, Phase III QUAZAR AML-001 Trial

Ravandi, Farhad; (...); Dombret, Herve

Meeting Abstract. 2020

Gastrointestinal events and management strategies for patients with acute myeloid leukemia (AML) in first remission receiving oral azacitidine (Oral-AZA) in the randomized, placebo-controlled, phase 3 QUAZAR AML-001 maintenance trial

Pfeilstocker, M.; (...); Dombret, H.

Meeting Abstract. 2021

Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia.

Mosquera Orgueira A; (...); Bello López JL

Article. 10.1371/journal.pone.0247093. 2021

Generalized non-evanescents wheals with targetoid purpuric plaques.

Sahuquillo-Torralba A; (...); Botella-Estrada R

Article. 10.1016/j.medcli.2017.10.006. 2018

GENES BELONGING TO THE SWI/SNF CHROMATIN REMODELING COMPLEXES ARE MUTATED AT HIGH FREQUENCY IN RARE T(11;17)(Q23;Q21)/ZBTB16-RARA ACUTE MYELOID LEUKEMIA PATIENTS

Fabiani, E.; (...); Voso, M. T.

Meeting Abstract. 2020

Genome wide DNA methylation profiling identifies specific epigenetic features in high-risk cutaneous squamous cell carcinoma.

Hervás-Marín D; (...); Sandoval J

Article. 10.1371/journal.pone.0223341. 2019

GETH-CLL4: Long-term follow-up of a pilot trial evaluating the addition of ofatumumab to the conditioning regimen of patients with chronic lymphocytic leukemia undergoing allogeneic HCT

Montesinos, Pau; (...); Delgado, Julio

Meeting Abstract. 2018

Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3 -Mutated AML.

Perl AE; (...); Levis MJ

Article. 10.1056/NEJMoa1902688. 2019

Gilteritinib prolongs survival in patients with FLT3-mutated relapsed/refractory acute myeloid leukaemia who have common AML comutations or a high FLT3-internal tandem duplication allelic ratio

Levis, MJ; (...); Bahceci, E

Meeting Abstract. 2020

Gilteritinib significantly prolongs overall survival in patients with FLT3-mutated (FLT3mut+) relapsed/refractory (R/R) acute myeloid leukemia (AML): Results from the Phase III ADMIRAL trial

Perl, AE; (...); Levis, MJ

Meeting Abstract. 10.1158/1538-7445.AM2019-CT184. 2019

GILTERITINIB SIGNIFICANTLY PROLONGS OVERALL SURVIVAL IN PATIENTS WITH FLT3-MUTATED RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA: RESULTS FROM THE PHASE 3 ADMIRAL TRIAL

Perl, A. E.; (...); Levis, M. J.

Meeting Abstract. 2019

Gilteritinib significantly prolongs overall survival in patients with FLT3-mutated relapsed/refractory acute myeloid leukemia: results from the phase 3 ADMIRAL trial

Perl, A. E.; (...); Levis, M. J.

Meeting Abstract. 2019

Gilteritinib use in the treatment of relapsed or refractory acute myeloid leukemia with a FLT3 mutation.

Ballesta-López O; (...); Montesinos P

Review. 10.2217/fon-2020-0700. 2020

Glasdegib (GLAS) plus low-dose cytarabine (LDAC) in AML or MDS: BRIGHT AML 1003 final report and four-year overall survival (OS) follow-up.

Heuser, M; (...); Cortes, JE

Meeting Abstract. 2020

Glasdegib plus low-dose cytarabine in acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS): BRIGHT AML 1003 final report and 4-year overall survival follow-up

Heuser, M; (...); Cortes, JE

Meeting Abstract. 2020

Glasdegib Plus Low-Dose Cytarabine in Acute Myeloid Leukemia or Myelodysplastic Syndrome: BRIGHT AML 1003 Final Report and 4-Year Overall Survival Follow-Up

Heuser, Michael; (...); Cortes, Jorge E.

Meeting Abstract. 2020

Glasdegib with LDAC in Newly Diagnosed Patients with Acute Myeloid Leukemia (AML) Unsuitable for Intensive Chemotherapy: Effects on Transfusions and Marrow Recovery vs LDAC Alone

Wang, ES; (...); Cortes, JE

Meeting Abstract. 10.1016/j.clml.2019.07.114. 2019

Glycemic variability in type 2 diabetes mellitus and acute coronary syndrome: liraglutide compared with insulin glargine: a pilot study

del Olmo-Garcia, MI; (...); Merino-Torres, JF

Article. 10.1177/0300060520926063. 2020

Haploidentical non-manipulated stem cell transplant in patients with non-hodgkin lymphoma: Spanish experience

Dorado, N; (...); Diez-Martin, JL

Meeting Abstract. 2019

Healthcare resource utilization in adult patients with relapsed/refractory FLT3 mutated acute myeloid leukemia: A retrospective chart review from Spain.

Solana-Altabella A; (...); Montesinos P

Article. 10.1111/ejh.13604. 2021

Health-Related Quality of Life (HRQoL) during Treatment with Enasidenib (ENA) Plus Azacitidine (AZA) in Patients with Newly Diagnosed Mutant IDH2 (m IDH2) Acute Myeloid Leukemia (AML) Not Eligible for Intensive Chemotherapy (IC)

DiNardo, Courtney D.; (...); Montesinos, Pau

Meeting Abstract. 10.1182/blood-2021-147601. 2021

Herpes vegetans of the vulva.

Abril-Pérez C; (...); Botella-Estrada R

Article. 10.1016/j.ajog.2021.05.024. 2021

HIF-1 alpha stabilization reduces retinal degeneration in a mouse model of retinitis pigmentosa

Olivares-Gonzalez, L; (...); Rodrigo, R

Article. 10.1096/fj.201700985R. 2018

High Oxygen Does Not Increase Reperfusion Injury Assessed with Lipid Peroxidation Biomarkers after Cardiac Arrest: A Post Hoc Analysis of the COMACARE Trial

Humaloja J; (...); Skrifvars MB

Article. 10.3390/jcm10184226. 2021

Higher versus Lower Oxygen Concentration during Respiratory Support in the Delivery Room in Extremely Preterm Infants: A Pilot Feasibility Study.

Law BHY; (...); Schmölzer GM

Article. 10.3390/children8110942. 2021

Histologic Analysis of Testes from Prepubertal Patients Treated with Chemotherapy Associates Impaired Germ Cell Counts with Cumulative Doses of Cyclophosphamide, Ifosfamide, Cytarabine, and Asparaginase.

Medrano, V, Jose; (...); Novella-Maestre, E.

Article. 10.1007/s43032-020-00357-6. 2021

How does SCORTEN score?

Navarro, IT; (...); Botella-Estrada, R

Meeting Abstract. 2019

Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort.

Stahl M; (...); Zeidan AM

Article. 10.1182/bloodadvances.2018016121. 2018

Hypoxic Preconditioning in the Fetal-to-Neonatal Transition Enhances Surfactant Stability against Oxidative Stress

Vento, M.; (...); Garcia-Verdugo, J. M.

Meeting Abstract. 2021

Iadademstat in Combination with Azacitidine Generates Robust and Long Lasting Responses in AML Patients (ALICE Trial)

Salamero, Olga; (...); Montesinos, Pau

Meeting Abstract. 10.1182/blood-2021-152183. 2021

Identification of a Novel Synthetic Lethal Vulnerability in Non-Small Cell Lung Cancer by Co-Targeting TMPRSS4 and DDR1

Redin, E; (...); Calvo, A

Meeting Abstract. 10.1016/j.jtho.2019.08.1485. 2019

Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1

Villalba, Maria; (...); Calvo, Alfonso

Article. 10.1038/s41598-019-51066-3. 2019

Identification of an episignature of human colorectal cancer associated with obesity by genome-wide DNA methylation analysis.

Crujeiras, AB; (...); Tinahones, FJ

Article. 10.1038/s41366-018-0065-6. 2019

Identification of Epigenetic Methylation Signatures With Clinical Value in Crohn's Disease.

Moret-Tatay I; (...); Beltrán B

Article. 10.14309/ctg.0000000000000083. 2019

IDH1-mutated relapsed or refractory AML: current challenges and future prospects

Megias-Vericat, JE; (...); Montesinos, P

Review. 10.2147/BLCTT.S177913. 2019

IL2 DECREASE AND INCREASE OF IL10 AND INF1A ARE ASSOCIATED TO CLINICAL ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOUSPATIENTS

Grau, E; (...); Roman, JA

Meeting Abstract. 10.1136/annrheumdis-2018-eular.6747. 2018

IL2 Decrease Is Associated to ANTI-DNA Positivity in Systemic LUPUS Erythematous Patients

Garcia, EG; (...); Ivorra, JAR

Meeting Abstract. 2018

Immunosuppressive profiles in liquid biopsy at diagnosis predict response to neoadjuvant chemotherapy in triple-negative breast cancer

Salvador-Coloma, C; (...); de Mora, JF

Article. 10.1016/j.ejca.2020.08.020. 2020

IMPACT OF ALLELIC STATUS OF TP53 MUTATIONS IN ACUTE MYELOID LEUKEMIA (AML)

Ibanez, Mariam; (...); Sanz, Guillermo

Meeting Abstract. 2020

Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.

Article. 10.1080/10428194.2020.1839650. 2020

Impact of Donor Human Milk in the Preterm Very Low Birth Weight Gut Transcriptome Profile by Use of Exfoliated Intestinal Cells.

Parra-Llorca A; (...); Vento M

Article. 10.3390/nu11112677. 2019

Impact of Gender on Molecular AML Subclasses - a Harmony Alliance Study

Matteuzzi, Tommaso; (...); Bullinger, Lars

Meeting Abstract. 10.1182/blood-2021-152215. 2021

Impact of Leukapheresis and Time to Chemotherapy on Outcomes of Newly Diagnosed Patients (pts) with Acute Myeloid Leukemia (AML) Presenting with Hyperleukocytosis: An Analysis from a Large International Patient Cohort

Stahl, M; (...); Zeidan, AM

Meeting Abstract. 10.1182/blood-2018-99-112495. 2018

Impact of maternal age on infants' emotional regulation and psychomotor development.

Moreno-Gimenez, Alba; (...); Garcia-Blanco, Ana

Article. 10.1017/S0033291721000568. 2021

Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia.

Paiva B; (...); PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatías Malignas) coop

Article. 10.1038/s41375-021-01126-3. 2021

Impact of the global financial crisis on newborn care in Portugal and Spain: Perception of health professionals.

Guimarães H; (...); Vento M

Editorial Material. 10.1111/apa.15067. 2020

Impact of uterine manipulator on oncological outcome in endometrial cancer surgery.

Padilla-Iserte P; (...); Domingo S

Article. 10.1016/j.ajog.2020.07.025. 2021

Improving the prediction of acute myeloid leukaemia outcomes by complementing mutational profiling with ex vivo chemosensitivity.

Onecha E; (...); Ayala R

Article. 10.1111/bjh.16432. 2020

Incidence and outcome after first molecular versus overt recurrence in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia included in the ALL Ph08 trial from the Spanish PETHEMA Group

Ribera, Josep-Maria; (...); Feliu, Evarist

Article. 10.1002/cncr.32156. 2019

Incidence and outcome of invasive fungal disease after front-line intensive chemotherapy in patients with acute myeloid leukemia: impact of antifungal prophylaxis.

Rodríguez-Veiga R; (...); Sanz GF

Article. 10.1007/s00277-019-03744-5. 2019

Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: a Biobadaderm cohort analysis.

Baniandrés-Rodríguez O; (...); García-Doval I

Letter. 10.1016/j.jaad.2020.10.046. 2021

Incomplete Mohs surgery: a long-term, nationwide prospective cohort to describe recurrence rate and risk factors (REGESMOHS, Spanish Registry of Mohs Surgery).

Oro-Ayude, M.; (...); REGESMOHS (Registro Español de Cirugía de Mohs)

Letter. 10.1111/jdv.17597. 2022

Increase of Neutrophil Activation Markers in Venous Thrombosis-Contribution of Circulating Activated Protein C

Martos L; (...); Medina P

Article. 10.3390/ijms21165651. 2020

INCREASED LEVELS OF FREE CIRCULATING DNA AND DNASE 1 ACTIVITY IN PLASMA IS ASSOCIATED WITH AN INCREASED RISK OF VENOUS THROMBOEMBOLISM

Oto, J.; (...); Medina, P.

Meeting Abstract. 2019

Increased survival due to lower toxicity for high-risk T-cell acute lymphoblastic leukemia patients in two consecutive pediatric-inspired PETHEMA trials

Barba, P; (...); Ribera, JM

Article. 10.1111/ejh.13178. 2019

Infectious pubic plaque.

Torres-Navarro, Ignacio; (...); Botella-Estrada, Rafael

Editorial Material. 10.1016/j.eimc.2019.03.004. 2019

Inflammatory bowel disease in patients over the age of 70y. Does the disease duration influence its behavior?

Huguet, JM; (...); Paredes, JM

Article. 10.1080/00365521.2018.1501603. 2018

Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia.

Article. 10.1097/FPC.0000000000000431. 2021

Influence of Sex on Gestational Complications, Fetal-to-Neonatal Transition, and Postnatal Adaptation

Lorente-Pozo, Sheila; (...); Vento, Maximo

Review. 10.3389/fped.2018.00063. 2018

INHIBITORS OF THE MUTATED DEHYDROGENASE (MIDH), IVOSIDENIB OR ENASIDENIB, IN COMBINATION WITH AZACITINE (AZA) IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)

Montesinos, P; (...); Vyas, P

Meeting Abstract. 2018

Integrative and comparative genomic analyses identify clinicallyrelevant pulmonary carcinoidgroups and unveil the supra-carcinoids.

Alcala N; (...); Fernandez-Cuesta L

Article. 10.1038/s41467-019-11276-9. 2019

INTENSIVE CHEMOTHERAPY VERSUS DECITABINE FIRST LINE LAM OVER 60 YEARS OLD

De la Fuente, A.; (...); Montesinos, P.

Meeting Abstract. 2019

Intercenter variability and factors associated with survival without bronchopulmonary dysplasia in extremely preterm newborns.

García-Muñoz Rodrigo F; (...); Vento M

Article. 10.1080/14767058.2019.1585423. 2019

Inter-center variability in neonatal outcomes of preterm infants: A longitudinal evaluation of 298 neonatal units in 11 countries.

Lui K; (...); International Network for Evaluating Outcomes of Neonates (iNeo) Investigators a

Article. 10.1016/j.siny.2021.101196. 2021

Intermittent hypoxemia and oxidative stress in preterm infants

Di Fiore, JM, Vento, M

Article. 10.1016/j.resp.2019.05.006. 2019

Intraperitoneal vancomycin in neonates during peritoneal dialysis: A case report

Company-Albir, MJ; (...); Poveda, JL

Article. 10.1111/jcpt.12842. 2019

Introduction.

Vento M, Poets CF

Editorial Material. 10.1016/j.siny.2020.101088. 2020

Invasive fungal disease in patients undergoing umbilical cord blood transplantation after myeloablative conditioning regimen

Montoro, J; (...); Pinana, JL

Article. 10.1111/ejh.13202. 2019

INVASIVE FUNGAL INFECTION IN ADULT PATIENTS SUBMITTED TO UMBILICAL CORD BLOOD TRANSPLANTATION

Montoro, J.; (...); Pinana, J. L.

Meeting Abstract. 2018

Is There a "Right" Amount of Oxygen for Preterm Infant Stabilization at Birth?

Oei JL, Vento M

Article. 10.3389/fped.2019.00354. 2019

Isoprostanoids Levels in Cerebrospinal Fluid Do Not Reflect Alzheimer's Disease

Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo

Article. 10.3390/antiox9050407. 2020

Jumping to conclusions in autism: integration of contextual information and confidence in decision-making processes.

Sahuquillo-Leal R; (...); García-Blanco A

Article. 10.1007/s00787-019-01409-2. 2020

Lipid peroxidation in neurodegeneration.

Review. 10.1016/j.cca.2019.07.037. 2019

Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapy

Martínez-Cuadrón D; (...); Sanz MA

Article. 10.1038/leu.2017.178. 2018

Long-Term Outcomes After Autologous Versus Allogeneic Stem Cell Transplantation in Molecularly-Stratified Patients With Intermediate Cytogenetic Risk Acute Myeloid Leukemia: A PETHEMA Study

Rodriguez-Arboli, E; (...); GETH Grp Espanol Trasplante Hemato

Article. 10.1016/j.jtct.2020.12.029. 2021

Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) Registry

Dauden, E; (...); Garcia-Doval, I

Article. 10.1016/j.jaad.2020.03.033. 2020

Long-term survival after intensive chemotherapy or hypomethylating agents in AML patients aged 70 years and older: a large patient data set study from European registries.

Recher, Christian; (...); Montesinos, Pau

Article. 10.1038/s41375-021-01425-9. 2022

Low-Dose Cytarabine With or Without Glasdegib in Newly Diagnosed Patients with Acute Myeloid Leukemia: Long-Term Analysis of a Phase 2 Randomized Trial

Papayannidis, C; (...); Cortes, JE

Meeting Abstract. 10.1016/j.clml.2019.07.111. 2019

Low-dose cytarabine with or without glasdegib in newly diagnosed patients with acute myeloid leukemia: Long-term analysis of a phase 2 randomized trial.

Smith, BD; (...); Cortes, JE

Meeting Abstract. 2019

Lymph Node Dissection in Patients with Melanoma and Sentinel Lymph Node Metastasis: An Updated, Evidence-Based Decision Algorithm

Moreno-Ramirez, D; (...); Academia Espanola Dermatologia Ven

Article. 10.1016/j.ad.2018.02.008. 2018

MAMI: a birth cohort focused on maternal-infant microbiota during early life

Garcia-Mantrana, I; (...); Atero, A

Article. 10.1186/s12887-019-1502-y. 2019

Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet

Sanz, MA; (...); Lo-Coco, F

Article. 10.1182/blood-2019-01-894980. 2019

Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial

Ravandi, F; (...); Dombret, H

Article. 10.1186/s13045-021-01142-x. 2021

Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study.

Stahl M; (...); Zeidan AM

Article. 10.1038/s41375-020-0783-3. 2020

MASS SEQUENCING DIRECTED TO THE STUDY OF REARRANGEMENTS AND CHANGES IN GENIC EXPRESSION IN ACUTE MYELOID LEUKEMIA

Sargas Simarro, C.; (...); Barragan Gonzalez, E.

Meeting Abstract. 2019

Maternal telomere length is shorter in intrauterine growth restriction versus uncomplicated pregnancies, but not in the offspring or in IVF-conceived newborns.

Perales-Puchalt A; (...); Blasco MA

Article. 10.1016/j.rbmo.2018.12.008. 2019

Mathematical simulation of Doppler changes in late-onset smallness; progression patterns of cerebral and umbilical anomalies define two types of late-onset fetal growth restriction.

Morales-Rosello, Jose; (...); Perales-Marin, Alfredo

Article. 10.1080/14767058.2019.1671346. 2021

Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial.

Simoes C; (...); Montesinos P

Article. 10.1182/bloodadvances.2020003195. 2021

Metabolic Phenotypes of Hypoxic-Ischemic Encephalopathy with Normal vs. Pathologic Magnetic Resonance Imaging Outcomes

Pineiro-Ramos, JD; (...); Vento, M

Article. 10.3390/metabo10030109. 2020

Metabolomics study to identify plasma biomarkers in alzheimer disease: ApoE genotype effect.

Article. 10.1016/j.jpba.2019.113088. 2020

microRNAs and Markers of Neutrophil Activation as Predictors of Early Incidental Post-Surgical Pulmonary Embolism in Patients with Intracranial Tumors

Oto, J; (...); Medina, P

Article. 10.3390/cancers12061536. 2020

MicroRNAs and Neutrophil Activation Markers Predict Venous Thrombosis in Pancreatic Ductal Adenocarcinoma and Distal Extrahepatic Cholangiocarcinoma.

Oto J; (...); Medina P

Article. 10.3390/ijms21030840. 2020

MicroRNAs expression associated with aggressive clinicopathological features and poor prognosis in primary cutaneous melanomas.

Murria Estal, Rosa; (...); Botella Estrada, Rafael

Article. 10.1097/CMR.0000000000000709. 2020

MiR-138-5p Suppresses Cell Growth and Migration in Melanoma by Targeting Telomerase Reverse Transcriptase.

Tarazon, Estefania; (...); Botella Estrada, Rafael

Article. 10.3390/genes12121931. 2021

miRNomic Signature in Very Low Birth-Weight Neonates Discriminates Late-Onset Gram-Positive Sepsis from Controls

Serna E; (...); Cernada M

Article. 10.3390/diagnostics11081389. 2021

MIRROS: a randomized, placebo-controlled, Phase III trial of cytarabine +/- idasanutlin in relapsed or refractory acute myeloid leukemia

Montesinos, P; (...); Fenaux, P

Article. 10.2217/fon-2020-0044. 2020

MIRROS: An ongoing randomized phase 3 trial of idasanutlin plus ARA-C in patients with relapsed or refractory acute myeloid leukemia.

Montesinos, P; (...); Fenaux, P

Meeting Abstract. 2019

Model selection for within-batch effect correction in UPLC-MS metabolomics using quality control - Support vector regression

Sanchez-Illana, A; (...); Kuligowski, J

Article. 10.1016/j.aca.2018.04.055. 2018

MODELING OF IDH2 GENE MUTATIONS IN THE CAENORHABDITIS ELEGANS ORGANISM. DEVELOPMENT OF A NEW STUDY MODEL

Gonzalez-Romero, E.; (...); Cervera-Zamora, J.

Meeting Abstract. 2021

Moderate to Severe Psoriasis in Pediatric and Young Patients: The BIOBADADERM Registry Experience.

Nieto Benito LM; (...); García-Doval I

Case Reports. 10.1016/j.ad.2021.05.017. 2022

Mohs micrographic surgery in dermatofibrosarcoma protuberans: Rate and risk factors for recurrence in a prospective cohort study from the Spanish Registry of Mohs Surgery (REGESMOHS) and review of the literature.

Nieto-Benito LM; (...); Garcia-Doval I

Review. 10.1111/exd.14291. 2021

Molecular Characteristics of Response to Olutasidenib (FT-2102) in Patients with Relapsed/Refractory mIDH(1) Acute Myeloid Leukemia

De Botton, Stephane; (...); Fenaux, Pierre

Meeting Abstract. 10.1182/blood-2021-144912. 2021

MOLECULAR CHARACTERIZATION OF ACUTE LEUKAEMIA OF CHILD, ADOLESCENT AND YOUNG ADULT THROUGH MASSIVE GUIDED SEQUENCING

Llop Garcia, M.; (...); Barragan Gonzalez, E.

Meeting Abstract. 2019

Molecular profiling refines minimal residual disease-based prognostic assessment in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia.

Ribera J; (...); Ribera JM

Article. 10.1002/gcc.22788. 2019

MONITORING MINIMUM RESIDUAL DISEASE (EMR) THROUGH NGS CONFIRMS PROGNOSTIC VALUE

De La Fuente, EO; (...); Diaz, RA

Meeting Abstract. 2018

Monitoring of system conditioning after blank injections in untargeted UPLC-MS metabolomic analysis.

Martínez-Sena T; (...); Kuligowski J

Article. 10.1038/s41598-019-46371-w. 2019

Monitoring of Urinary Oxidative Stress Biomarker Levels in Newborns with Hypoxic-Ischemic Encephalopathy

Vilaplana, MMC; (...); Kuligowski, Julia

Meeting Abstract. 10.1016/j.freeradbiomed.2020.10.291. 2020

Moral reasoning and moral conflict in patients of the amyotrophic lateral sclerosis - Frontotemporal dementia spectrum.

Serrano-Pastor, Lucas; (...); Vazquez-Costa, Juan F

Article. 10.1080/17470919.2020.1850521. 2020

MORPHOLOGICAL CHARACTERIZATION OF THE CUTANEOUS BIOPSIES IN THE EICH: INFLAMMATORY INFILTRATION STUDY AND THE EXPRESSION OF ELAFIN

Moles Poveda, P.; (...); Sanz Caballer, J.

Meeting Abstract. 2018

Mother's Bed Incline and Desaturation Episodes in Healthy Term Newborns during Early Skin-to-Skin Contact: A Multicenter Randomized Controlled Trial.

Rodríguez-López J; (...); Pallás-Alonso CR

Article. 10.1159/000519387. 2021

MTHFR and VDR Polymorphisms Improve the Prognostic Value of MYCN Status on Overall Survival in Neuroblastoma Patients

Olivera, GG; (...); Herrero, MJ

Article. 10.3390/ijms21082714. 2020

Multicenter, Open-Label, 3-Arm Study of Gilteritinib, Gilteritinib Plus Azacitidine, or Azacitidine Alone in Newly Diagnosed FLT3 Mutated (FLT3(mut+)) Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Induction Chemotherapy: Findings from the Safety Cohort

Esteve, J; (...); Bahceci, E

Meeting Abstract. 10.1182/blood-2018-99-110976. 2018

Multicentre Implementation of Next Generation Sequencing to Acute Myeloid Leukemia Patients in PETHEMA Spanish Collaborative Group

Sargas, C; (...); Barragan, E

Meeting Abstract. 2019

Multi-omics comparative analyses of pulmonary typical carcinoids, atypical carcinoids, and large-cell neuroendocrine carcinoma

Leblay, N; (...); Fernandez-Cuesta, L

Meeting Abstract. 10.1158/1538-7445.AM2018-5358. 2018

Mutant IDH (mIDH) inhibitors, ivosidenib or enasidenib, with azacitidine (AZA) in patients with acute myeloid leukemia (AML).

Dinardo, CD; (...); Vyas, P

Meeting Abstract. 10.1200/JCO.2018.36.15_suppl.7042. 2018

Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia

Fabiani E; (...); Voso MT

Article. 10.1002/cam4.3904. 2021

Myocardial Infarction in Neonates: A Diagnostic and Therapeutic Challenge

Martinez, MR; (...); Carrascosa, MA

Article. 10.1155/2019/7203407. 2019

NAC and Vitamin D Improve CNS and Plasma Oxidative Stress in Neonatal HIE and Are Associated with Favorable Long-Term Outcomes

Jenkins DD; (...); Wiest DB

Article. 10.3390/antiox10091344. 2021

Nasogastric tube utilization after esophagectomy: an unnecessary gesture?

Menéndez-Jiménez M; (...); García-Granero E

Article. 10.1016/j.ciresp.2020.04.021. 2020

NATIONAL EXPERIENCE WITH THE USE OF VENETOCLAX IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA

Labrador, J.; (...); Montesinos, P.

Meeting Abstract. 2020

National protocol led to significant improvements in follow-up programmes for very low birth weight or very preterm infants.

Loureiro B; (...); Pallás-Alonso CR

Article. 10.1111/apa.15864. 2021

Neonatal Outcomes in Very Preterm Infants With Severe Congenital Heart Defects: An International Cohort Study.

Norman M; (...); International Network for Evaluation of Outcomes in Neonates (iNeo) Investigator

Article. 10.1161/JAHA.119.015369. 2020

Neonatal outcomes of extremely preterm twins by sex pairing: an international cohort study.

Gagliardi L; (...); International Network for Evaluating Outcomes of Neonates (iNeo) Investigators

Article. 10.1136/archdischild-2020-318832. 2021

Neonatal Outcomes of Very Preterm or Very Low Birth Weight Triplets

Shah, Prakesh S.; (...); International Network for Evaluation of Outcomes (iNEO) in Neonates Investigator

Article. 10.1542/peds.2018-1938. 2018

Neonatal Resuscitation and Postresuscitation Care of Infants Born to Mothers with Suspected or Confirmed SARS-CoV-2 Infection

Chandrasekharan P; (...); Lakshminrusimha S

Article. 10.1055/s-0040-1709688. 2020

Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project.

Sargas C; (...); Montesinos P

Article. 10.3324/haematol.2020.263806. 2021

Neurodevelopmental outcomes of preterm infants after randomisation to initial resuscitation with lower (FiO 2 < 0.3) or higher (FiO 2 > 0.6) initial oxygen levels. An individual patient meta-analysis.

Oei JL; (...); Vento M

Article. 10.1136/archdischild-2021-321565. 2021

Neuropsychological assessment and cortisol levels in biofluids from early Alzheimer's disease patients

Pena-Bautista, C.; (...); Chafer-Pericas, C.

Article. 10.1016/j.exger.2019.05.007. 2019

New screening approach for Alzheimer's disease risk assessment from urine lipid peroxidation compounds.

Peña-Bautista C; (...); Chafer-Pericas, C

Article. 10.1038/s41598-019-50837-2. 2019

Newborn Resuscitation in Settings Without Access to Supplemental Oxygen

Shukla, V, Carlo, WA, Vent, M

Article. 10.1016/j.clp.2019.05.014. 2019

Newly validated biomarkers of brain damage may shed light into the role of oxidative stress in the pathophysiology of neurocognitive impairment in dietary restricted phenylketonuria patients

Rausell, Dolores; (...); Chafer-Pericas, Consuelo

Review. 10.1038/s41390-018-0202-x. 2019

Nicord Single Unit Expanded Umbilical Cord Blood Transplantation (UCBT): Final Results of a Multicenter Phase I/II Trial

Horwitz, ME; (...); Sanz, G

Meeting Abstract. 10.1016/j.bbmt.2017.12.628. 2018

Nitric oxide and preterm resuscitation: some words of caution.

Vento M, Sánchez-Illana Á

Editorial Material. 10.1038/s41390-019-0649-4. 2020

Noninvasive monitoring of evolving urinary metabolic patterns in neonatal encephalopathy.

Piñeiro-Ramos JD; (...); Vento M

Article. 10.1038/s41390-021-01553-z. 2021

Non-invasive monitoring of saliva can be used to identify oxidative stress biomarkers in preterm and term newborn infants

Solaz-Garcia, Alvaro; (...); Saenz-Gonzalez, Pilar

Article. 10.1111/apa.16073. 2021

Non-invasive monitoring of stress biomarkers in the newborn period.

Peña-Bautista C; (...); Vento M

Article. 10.1016/j.siny.2019.04.002. 2019

Obesity is a risk factor for acute promyelocytic leukemia: evidence from population and cross-sectional studies studies and correlation with flt3 mutations and polyunsaturated fatty acid metabolism.

Mazzarella L; (...); Pelicci PG

Article. 10.3324/haematol.2019.223925. 2020

Olutasidenib (FT-2102) in Combination with Azacitidine Induces Durable Complete Remissions in Patients with mIDH1 Acute Myeloid Leukemia

Cortes, Jorge E.; (...); Wei, Andrew H.

Meeting Abstract. 10.1182/blood-2021-144905. 2021

Olutasidenib (FT-2102), an IDH1m Inhibitor As a Single Agent or in Combination with Azacitidine, Induces Deep Clinical Responses with Mutation Clearance in Patients with Acute Myeloid Leukemia Treated in a Phase 1 Dose Escalation and Expansion Study

Watts, Justin M.; (...); Cortes, Jorge E.

Meeting Abstract. 10.1182/blood-2019-123920. 2019

Omics-based Biomarkers for the Early Alzheimer Disease Diagnosis and Reliable Therapeutic Targets Development

Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo

Review. 10.2174/1570159X16666180926123722. 2019

On-Capillary Surface-Enhanced Raman Spectroscopy: Determination of Glutathione in Whole Blood Microsamples

Sanchez-Illana, Angel; (...); Kuligowski, Julia

Article. 10.1021/acs.analchem.8b01492. 2018

Optimal Inspired Fraction of Oxygen in the Delivery Room for Preterm Infants

Lara-Canton, Inmaculada; (...); Vento, Maximo

Review. 10.3390/children6020029. 2019

Optimizing Oxygenation of the Extremely Premature Infant during the First Few Minutes of Life: Start Low or High?

Saugstad OD, Lakshminrusimha S, Vento M

Editorial Material. 10.1016/j.jpeds.2020.07.034. 2020

Oral Azacitidine (Oral-AZA) improves Overall Survival (OS) and Relapse-free Survival (RFS) for patients with Acute Myeloid Leukemia (AML) in first remission after Intensive Chemotherapy (IC), regardless of amount of consolidation received: Results of the QUAZAR AML-001 maintenance trial

Dohner, H.; (...); Ravandi, F.

Meeting Abstract. 2021

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission.

Wei AH; (...); Roboz GJ

Article. 10.1056/NEJMoa2004444. 2020

OroPharyngeal therapy with mother's own milk (OPT-MOM) improves feeding and reduces length of stay in premature infants

Garofalo, Nancy; (...); Caplan, Michael

Meeting Abstract. 2021

Outcome of a Real-Life Population of Patients With Acute Promyelocytic Leukemia Treated According to the PETHEMA Guidelines: The Polish Adult Leukemia Group (PALG) Experience.

Sobas M; (...); Giebel S

Article. 10.1016/j.clml.2019.09.616. 2020

Outcome of Acute Myeloid Leukemia with Inv(3)(Q21q26.2)/ T(3;3)(Q21;Q26.2). Experience of the Spanish PETHEMA and CETLAM Groups

Sitges, M; (...); CETLAM Cooperative Grp

Meeting Abstract. 2019

Outcome of older (=70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study.

Kayser S; (...); Montesinos P

Article. 10.1038/s41375-020-0758-4. 2020

Outcome of older (>= 70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study (vol 34, pg 2333, 2020)

Kayser, Sabine; (...); Montesinos, Pau

Correction. 10.1038/s41375-021-01358-3. 2021

Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials

Ribera, JM; (...); PETHEMA Grp

Article. 10.1002/hon.2910. 2021

Outcomes for Patients with Late-Stage Mutant-IDH2 (m IDH2) Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) Treated with Enasidenib Vs Other Lower-Intensity Therapies in the Randomized, Phase 3 IDHentify Trial

DiNardo, Courtney D.; (...); de Botton, Stephane

Meeting Abstract. 10.1182/blood-2021-147593. 2021

Outcomes of delivery room resuscitation of bradycardic preterm infants: A retrospective cohort study of randomised trials of high vs low initial oxygen concentration and an individual patient data analysis

Kapadia V; (...); Vento M

Article. 10.1016/j.resuscitation.2021.08.023. 2021

Outcomes of Patients with Newly-Diagnosed Acute Myeloid Leukemia and Hyperleukocytosis Who Did Not Undergo Intensive Chemotherapy: Results from a Large International Database

Shallis, RM; (...); Zeidan, AM

Meeting Abstract. 10.1182/blood-2018-99-119755. 2018

Oxidative Damage of DNA as Early Marker of Alzheimer's Disease.

Article. 10.3390/ijms20246136. 2019

Oxidative stress - Related spontaneous preterm delivery challenges in causality determination, prevention and novel strategies in reduction of the sequelae.

Stefanovic V, Andersson S, Vento M

Article. 10.1016/j.freeradbiomed.2019.06.008. 2019

Oxidative stress biomarkers in the preterm infant.

Sánchez-Illana Á; (...); Kuligowski J

Review. 10.1016/bs.acc.2020.08.011. 2020

Oxidative Stress in the Newborn Period: Useful Biomarkers in the Clinical Setting

Millan, Ivan; (...); Vento, Maximo

Review. 10.3390/antiox7120193. 2018

Oxidative stress in the perinatal period.

Vento M

Editorial Material. 10.1016/j.freeradbiomed.2019.07.028. 2019

Oxygen and preterm infant resuscitation: what else do we need to know?

Oei, JL, Saugstad, OD, Vento, M

Review. 10.1097/MOP.0000000000000610. 2018

Oxygen for the delivery room respiratory support of moderate-to-late preterm infants. An international survey of clinical practice from 21 countries

Sotiropoulos, James X.; (...); Oei, Ju Lee

Article. 10.1111/apa.16091. 2021

Oxygen in the neonatal period: Oxidative stress, oxygen load and epigenetic changes.

Lorente-Pozo S; (...); Vento M

Article. 10.1016/j.siny.2020.101090. 2020

Oxygen needs during resuscitation and surfactant to achieve stabilisation were independent risks factors for pulmonary interstitial emphysema in preterm infants

Nunez-Ramiro, Antonio; (...); Vento, Maximo

Article. 10.1111/apa.14048. 2018

Oxygen saturation (SpO2) targeting for newborn infants at delivery: Are we reaching for an impossible unknown?

Bhushan Gottimukkala S; (...); Oei JL

Article. 10.1016/j.siny.2021.101220. 2021

Oxygen Supplementation During Preterm Stabilization and the Relevance of the First 5 min After Birth.

Lara-Cantón I; (...); Vento M

Review. 10.3389/fped.2020.00012. 2020

Oxygen Therapy for Preterm Infants Preface

Carlo, Waldemar A., Vento, Maximo

Editorial Material. 10.1016/j.clp.2019.06.001. 2019

Oxygen therapy of the newborn from molecular understanding to clinical practice

Saugstad, OD; (...); Vento, M

Review. 10.1038/s41390-018-0176-8. 2019

Pancreatic panniculitis.

Torres-Navarro I, Rojas-Ferrer N, Botella-Estrada R

Article. 10.17235/reed.2019.6116/2018. 2019

Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol

Garcia-Robles, Ana; (...); Carrascosa, MA

Article. 10.3389/fped.2020.00372. 2020

Paradoxical psoriasiform reactions by anti-TNF treated with Ustekinumab in patients with inflammatory bowel disease

Meeting Abstract. 2019

Partial T Cell-Depleted Peripheral Blood Stem Cell Transplantation from HLA-Identical Sibling Donors for Patients with Severe Aplastic Anemia.

Sanz J; (...); Piñana JL

Article. 10.1016/j.bbmt.2019.08.020. 2020

Patient Reported Outcomes in Patients with Newly Diagnosed FLT3(mut+) acute Myeloid Leukemia Ineligible for Intensive Induction Chemotherapy from Lacewing: A Randomized Phase 3 Trial of Gilteritinib and Azacitidine Versus Azacitidine Alone

Wang, Eunice S.; (...); Shah, Manasee V.

Meeting Abstract. 10.1182/blood-2021-144977. 2021

Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry.

Sánchez-Velázquez A; (...); Ortiz-Romero PL

Letter. 10.1111/jdv.17430. 2021

Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study

Rodriguez-Medina, C; (...); Fernandez, PM

Article. 10.1016/j.leukres.2020.106352. 2020

Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia

Stahl, M; (...); Zeidan, AM

Letter. 10.1080/10428194.2018.1468893. 2019

PERINATAL HYPOXIC PRECONDITIONING INDUCES SURFACTANT SYNTHESIS AND PREVENTS LUNG DAMAGE AFTER AN HYPEROXIC INSULT IN A MICE MODEL OF THE FNT

Isabel, Torres-Cuevas; (...); Maximo, Vento

Meeting Abstract. 2019

Personalized Survival Prediction of Patients With Acute Myeloblastic Leukemia Using Gene Expression Profiling

Orgueira, AM; (...); Lopez, JLB

Article. 10.3389/fonc.2021.657191. 2021

PHARMACOGENETIC VARIANTS ASSOCIATED WITH TREATMENT RESPONSE IN NEUROBLASTOMA

Olivera, G; (...); Alino, SF

Meeting Abstract. 2018

Phase 3, Open-Label, Randomized Study of Gilteritinib and Azacitidine Vs Azacitidine for Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia in Patients Ineligible for Intensive Induction Chemotherapy

Wang, Eunice S.; (...); Tiu, Ramon V.

Meeting Abstract. 10.1182/blood-2021-145379. 2021

Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide

Horwitz, ME; (...); Sanz, G

Article. 10.1200/JCO.18.00053. 2019

Plasma alterations in cholinergic and serotonergic systems in early Alzheimer Disease: Diagnosis utility.

Article. 10.1016/j.cca.2019.10.023. 2020

Plasma isoprostanoids assessment as Alzheimer's disease progression biomarkers.

Article. 10.1111/jnc.15183. 2020

Plasma lipid peroxidation biomarkers for early and non-invasive Alzheimer Disease detection

Pena-Bautista, C; (...); Chafer-Pericas, C

Article. 10.1016/j.freeradbiomed.2018.06.038. 2018

Plasma metabolomics in early Alzheimer's disease patients diagnosed with amyloid biomarker

Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo

Article. 10.1016/j.jprot.2019.04.008. 2019

Plasma Oncostatin M, TNF-a, IL-7, and IL-13 Network Predicts Crohn's Disease Response to Infliximab, as Assessed by Calprotectin Log Drop.

Mateos B; (...); Beltrán B

Article. 10.1159/000508069. 2020

PLASMATIC DNA STIMULATES THE GENERATION OF IN VITRO THROMBIN EVEN IN THE ABSENCE OF EXTRINSIC TISSUE FACTOR AND CAN BE REVERSED WITH DNA'S

Fernandez-Pardo, A.; (...); Medina, P.

Meeting Abstract. 2019

PLZF-RAR(alpha), NPM1-RAR(alpha), and Other Acute Promyelocytic Leukemia Variants: The PETHEMA Registry Experience and Systematic Literature Review

Sobas, M; (...); Montesinos, P

Review. 10.3390/cancers12051313. 2020

PONATINIB AND CHEMOTHERAPY IN YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA WITH PHILADELPHIA CHROMOSOME. RESULTS OF THE PONALFIL CLINICAL TRIAL WITH COMPLETE RECRUITMENT

Ribera, J. M.; (...); Garcia-Sanz, R.

Meeting Abstract. 2020

PONATINIB AND CHEMOTHERAPY IN YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA WITH PHILADELPHIA CHROMOSOME. PRELIMINARY RESULTS OF THE PONALFIL CLINICAL TRIAL

Ribera Santasusana, J. M.; (...); Garcia-Sanz, R.

Meeting Abstract. 2019

PONATINIB AND CHEMOTHERAPY IN YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA WITH PHILADELPHIC CHROMOSOME (LAL PH plus ). RESULTS OF THE PONALFIL CLINICAL TRIAL WITH MEDIUM 2-YEAR FOLLOW-UP

Ribera Santasusana, J. M.; (...); Garcia-Sanz, R.

Meeting Abstract. 2021

Ponatinib and Chemotherapy in Young Adults with De Novo Philadelphia Chromosome-Positive Acute Lymphoblstic Leukemia. Preliminary Results of Ponalfil Clinical Trial

Ribera, Josep-Maria; (...); Garcia-Sanz, Ramon

Meeting Abstract. 10.1182/blood-2019-125558. 2019

Position statement for the management of comorbidities in psoriasis

Dauden, E; (...); Rivera, R

Article. 10.1111/jdv.15177. 2018

Potential Value of Maternal Oxygen Supplementation.

Saugstad OD, Vento M

Letter. 10.1001/jamapediatrics.2021.0364. 2021

Practical Considerations for Treatment of Relapsed/Refractory FLT3-ITD Acute Myeloid Leukaemia with Quizartinib: Illustrative Case Reports.

Martínez-Cuadrón D; (...); Montesinos P

Article. 10.1007/s40261-019-00881-7. 2020

Precision medicine in acute myeloid leukemia: where are we now and what does the future hold?

Review. 10.1080/17474086.2020.1818559. 2020

Precision Medicine Test Is Similar but Faster Than Conventional Cytogenetics Predicting Response in AML Patients and Provides Alternative Treatments

Ballesteros, J; (...); Montesinos, P

Meeting Abstract. 10.1182/blood-2018-99-115849. 2018

Predictive factors of immune tolerance treatment response in severe haemophilia A patients with inhibitors: A real-world report from a single centre, mixed retrospective-prospective long-term study

Haya, S; (...); Casana, P

Letter. 10.1111/hae.13660. 2019

Predictive value of isolated CSF NfL and Chi3l1 measures in clinical practice

Gil-Perotin, S; (...); Casanova-Estruch, B

Meeting Abstract. 2018

Preterm Gut Microbiome Depending on Feeding Type: Significance of Donor Human Milk

Parra-Llorca, A; (...); Collado, MC

Article. 10.3389/fmicb.2018.01376. 2018

Prevention, recognition, and management of adverse events associated with gemtuzumab ozogamicin use in acute myeloid leukemia.

Cortes JE; (...); Wang ES

Review. 10.1186/s13045-020-00975-2. 2020

Preventive bundle approach decreases the incidence of ventilator-associated pneumonia in newborn infants.

Pinilla-González A; (...); Cernada M

Article. 10.1038/s41372-021-01086-7. 2021

Preventive strategies and factors associated with surgically treated necrotising enterocolitis in extremely preterm infants: an international unit survey linked with retrospective cohort data analysis.

Adams M; (...); International Network for EvaluatingOutcomes (iNeo) of Neonates

Article. 10.1136/bmjopen-2019-031086. 2019

Primary cutaneous embryonal rhabdomyosarcoma with desmoplastic growth pattern and anaplastic lymphoma kinase overexpression. Report of a case with special emphasis on the differential diagnosis.

Sabater-Marco V; (...); Botella-Estrada R

Letter. 10.1111/ced.13877. 2019

Primary cutaneous lymphomas in children: A prospective study from the Spanish Academy of Dermatology and Venereology (AEDV) Primary Cutaneous Lymphoma Registry.

Torre-Castro J; (...); Machan S

Article. 10.1111/pde.14811. 2021

Probiotic characterization of Lactobacillus strains isolated from breast milk and employment for the elaboration of a fermented milk product

Luz, Carlos; (...); Meca, Giuseppe

Article. 10.1016/j.jff.2021.104599. 2021

Prognosis and Survival of Acute Myeloid Leukemia: Experience of a Single Center in Colombia

Sossa, CL; (...); Jimenez, SI

Meeting Abstract. 10.1182/blood-2018-99-119927. 2018

Prognosis Value of Measurable Residual Disease By Multiparameter Flow Cytotometry in Patients with Acute Myeloblastic Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation

Caballero, Teresa; (...); Perez-Simon, Jose A.

Meeting Abstract. 10.1182/blood-2021-151533. 2021

PROGNOSIS VALUE OF MINIMAL DETECTABLE DISEASE (MDD) BY 2(nd) GENERATION ALLOGENIC PRE-TRANSPLANTATION CYTOMETRY IN PATIENTS WITH ACUTE MYELOBLASTIC LEUKEMIA

Velazquez Teresa, Caballero; (...); Jose Antonio, Perez Simon

Meeting Abstract. 2021

Prognostic factors of overall (OS) and relapse-free survival (RFS) for patients with acute myeloid leukemia (AML) in remission after intensive chemotherapy (IC): Multivariate analyses from the QUAZAR AML-001 trial of oral azacitidine (Oral-AZA).

Roboz, Gail J.; (...); Dohner, Hartmut

Meeting Abstract. 10.1200/JCO.2021.39.15_suppl.7014. 2021

Prognostic Impact of NPM1 and FLT3 Mutations at Diagnosis and Presence of Measurable Residual Disease (MRD) after Intensive Chemotherapy (IC) for Patients with Acute Myeloid Leukemia (AML) in Remission: Outcomes from the QUAZAR AML-001 Trial of Oral Azacitidine (Oral-AZA) Maintenance

Dohner, Hartmut; (...); de Menezes, Daniel Lopes

Meeting Abstract. 10.1182/blood-2021-147465. 2021

Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens.

Castaño-Bonilla T; (...); Montesinos, P

Article. 10.1038/s41598-021-00050-x. 2021

Progression of Doppler changes in early-onset small for gestational age fetuses. How frequent are the different progression sequences?

Morales-Rosello, J; (...); Perales-Marin, A

Article. 10.1080/14767058.2017.1304910. 2018

PROPOSED MOLECULAR CLASSIFICATION OF ACUTE MYELOBLASTIC LEUKEMIA (AML) BASED ON SPLICING EVENTS

Liquori, A.; (...); Cervera Zamora, J.

Meeting Abstract. 2021

Prospective Randomized Study Comparing Myeloablative Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Stem Cell Transplantation for Adults with Hematologic Malignancies.

Sanz J; (...); Piñana JL

Article. 10.1016/j.bbmt.2019.10.014. 2020

Protein Oxidation Biomarkers and Myeloperoxidase Activation in Cerebrospinal Fluid in Childhood Bacterial Meningitis.

Rugemalira E; (...); Vento M

Article. 10.3390/antiox8100441. 2019

Pyoderma Gangrenosum With Ulcerative Colitis Successfully Treated With Ustekinumab.

Piqueras-García J; (...); Botella-Estrada R

Letter. 10.1016/j.ad.2018.03.034. 2019

Quantitative Evaluation of Neonatal Brain Elasticity Using Shear Wave Elastography.

Garcés Iñigo E; (...); Martí-Bonmatí L

Article. 10.1002/jum.15464. 2020

QuANTUM-R: phase 3, randomised trial of Quizartinib in patients with FLT3-Internal tandem duplication (FLT3-ITD)-positive relapsed/refractory (R/R) acute myeloid meukaemia (AML)

Radsak, M. P.; (...); Levis, M. J.

Meeting Abstract. 2019

Quizartinib in FLT3-ITD-Mutated Relapsed/Refractory Acute Myeloid Leukemia: QuANTUM-R Trial Results

Cortes, JE; (...); Levis, MJ

Meeting Abstract. 10.1093/annonc/mdz374.003. 2019

Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial

Cortes, JE; (...); Levis, MJ

Article. 10.1016/S1470-2045(19)30150-0. 2019

Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome

Cortes, JE; (...); Heuser, M

Article. 10.1038/s41375-018-0312-9. 2019

Rapidly growing retroarticular tumor: the importance of physical examination

Torres-Navarro, I, Piqueras-Garcia, J, Botella-Estrade, R

Editorial Material. 2018

Rapidly progressive frontal necrotic plaque in an immunosuppressed host

Sanz, Jaime, Montesinos, Pau, Sanz, Miguel A

Editorial Material. 10.1016/j.eimc.2017.01.003. 2018

Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA plus )

Falantes, J; (...); European ALMA?+?Investigators

Article. 10.1080/10428194.2017.1365854. 2018

Real life outcomes of patients aged =75 years old with acute promyelocytic leukemia: experience of the PETHEMA registry.

Salamero O; (...); PETHEMA and PALG Groups

Article. 10.1080/10428194.2019.1607327. 2019

REAL-LIFE EVIDENCE OF VENETOCLAX TREATMENT IN PATIENTS WITH ACUTE REPLAPSE OR REFRACTORY LEUKEMIA MYELOID

Jorge, Labrador; (...); Pau, Montesinos

Meeting Abstract. 2021

Real-world long-term effectiveness of ustekinumab in Crohn's disease: Results from the ENEIDA registry

Iborra Colomino, M. I.; (...); Nos, P.

Meeting Abstract. 2020

Real-world short-term effectiveness of ustekinumab in 305 patients with Crohn's disease: results from the ENEIDA registry

Iborra, M; (...); Chaparro, M

Article. 10.1111/apt.15371. 2019

Real-world short-term effectiveness of ustekinumab in Crohn's disease: Results from the ENEIDA Registry

Iborra, M; (...); Nos, P

Meeting Abstract. 10.1093/ecco-jcc/jjy222.629. 2019

Redox Status, Dose and Antioxidant Intake in Healthcare Workers Occupationally Exposed to Ionizing Radiation

Sebastia, N; (...); Rodrigo, R

Article. 10.3390/antiox9090778. 2020

Relationship between structural damage with loss of strength and functional disability in psoriatic arthritis patients.

Feced Olmos CM; (...); Román Ivorra JA

Article. 10.1016/j.clinbiomech.2019.06.009. 2019

Reliable determination of new lipid peroxidation compounds as potential early Alzheimer Disease biomarkers

Garcia-Blanco, Ana; (...); Chafer-Pericas, Consuelo

Article. 10.1016/j.talanta.2018.03.002. 2018

REMOVAL OF GERMINAL LINE MUTATIONS IN PATIENTS WITH MDS AND AML: WHO SHOULD BE PERFORMED?

Santiago, Marta; (...); Cervera, Jose

Meeting Abstract. 2020

Reply to letter to the editor: "The psychiatric risks of temporal epilepsy surgery. What should patients be told?"

Iranzo-Tatay, C; (...); Villanueva, V

Letter. 10.1016/j.yebeh.2017.09.004. 2018

Reply.

Saugstad OD, Lakshminrusimha S, Vento M

Letter. 10.1016/j.jpeds.2020.11.018. 2021

RESCUE TREATMENT WITH DECITABINE AFTER PROGRESSION TO AZACITIDINE IN AML

De la Fuente, A; (...); Montesinos, P

Meeting Abstract. 2018

Respiratory Management of Extremely Preterm Infants: An International Survey

Beltempo, Marc; (...); Int Network Evaluating Outcomes Ne

Article. 10.1159/000487987. 2018

Response To Dr. Kumar: Cord milking in preterm.

Toledo, J. D., Vento, M.

Letter. 10.1038/s41372-019-0466-y. 2019

Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS)

Kantarjian, Hagop M.; (...); Chiao, Judy H.

Article. 10.1002/cncr.33828. 2021

RESULTS OF THE TREATMENT OF LYMPHOBLASTIC LYMPHOMA WITH PROTOCOLS OF LYMPHOBLASTIC ACUTE LEUKEMIA OF PETHEMA GROUP

Sagues, M.; (...); Ribera, J. M.

Meeting Abstract. 2019

Risk assessment of exposure to phthalates in breastfeeding women using human biomonitoring

Dualde, P; (...); Yusa, V

Article. 10.1016/j.chemosphere.2020.127003. 2020

Risk Factors and Rate of Recurrence after Mohs Surgery in Basal Cell and Squamous Cell Carcinomas: A Nationwide Prospective Cohort (REGESMOHS, Spanish Registry of Mohs Surgery)

Tomas-Velazquez, Alejandra; (...); Redondo, Pedro

Article. 10.2340/actadv.v101.544. 2021

Rituximab and Specific Therapy for Patients with Burkitt's Leukemia and Lymphoma. Results of the BURKIMAB14 Trial from the Spanish Pethema and Geltamo Groups in 80 Patients

Ribera, Josep-Maria; (...); Sancho, Juan-Manuel

Meeting Abstract. 10.1182/blood-2019-125683. 2019

Role of Hematopoietic Stem Cell Transplantation in Acute Promyelocytic Leukemia.

Review. 10.3389/fonc.2021.614215. 2021

Role of Measurable Residual Disease (MRD) in Redefining Complete Response (CR) in Elderly Patients with Acute Myeloid Leukemia (AML): Results from the Pethema-Flugaza Phase III Clinical Trial

Paiva, B; (...); Montesinos, P

Meeting Abstract. 10.1182/blood-2018-99-113299. 2018

Safety and Efficacy from a Phase 1b/2 Study of IMGN632 in Combination with Azacitidine and Venetoclax for Patients with CD123-Positive Acute Myeloid Leukemia

Daver, Naval; (...); Sweet, Kendra

Meeting Abstract. 10.1182/blood-2021-146503. 2021

Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study.

Montesinos P; (...); Wei AH

Article. 10.1038/s41375-020-0773-5. 2020

Salvage regimens using conventional chemotherapy agents for relapsed/refractory adult AML patients: a systematic literature review

Megias-Vericat, JE; (...); Montesinos, P

Review. 10.1007/s00277-018-3304-y. 2018

SCREENING FOR POTENTIAL THERAPEUTIC OPPORTUNITIES FOR B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS WITH IKZF1 DELETIONS

Ribera, Jordi; (...); Ribera, Josep Maria

Meeting Abstract. 2020

Seeking biomarkers that predict neurodevelopmental impairment in preterm infants.

Cascant-Vilaplana MM, Vento M

Article. 10.1016/j.ebiom.2021.103657. 2021

SEL24/MEN1703 Inhibits PIM/FLT3 Downstream Target in Acute Myeloid Leukemia (AML) Patients: Results of the Pharmacodynamics (PD) Assay and Genomic Profiling in the First-in-Human Diamond-01 Trial

Paoli, Alessandro; (...); Pellacani, Andrea

Meeting Abstract. 10.1182/blood-2021-150277. 2021

Selection and management of older patients with acute myeloid leukemia treated with glasdegib plus low-dose cytarabine: expert panel review.

Cortes JE; (...); Heuser M

Review. 10.1080/10428194.2020.1817445. 2020

Sentinel Lymph Node Biopsy vs. Observation in Thin Melanoma: A Multicenter Propensity Score Matching Study.

Tejera-Vaquerizo, Antonio; (...); Nagore, Eduardo

Article. 10.3390/jcm10245878. 2021

SfM-3DULC: Reliability of a new 3D wound measurement procedure and its accuracy in projected area.

Sánchez-Jiménez D; (...); Botella-Estrada R

Article. 10.1111/iwj.13595. 2021

Sonidegib in the Treatment of Locally Advanced Basal Cell Carcinoma.

Sanmartín O; (...); Puig S

Review. 10.1016/j.ad.2020.11.002. 2021

Spanish survey on follow-up programmes for children born very preterm.

Pallás-Alonso CR; (...); Vento M

Article. 10.1111/apa.14647. 2019

Sparse N-way partial least squares by L1-penalization

Hervas, D; (...); Ferrer, A

Article. 10.1016/j.chemolab.2019.01.004. 2019

Sparse N-way partial least squares with R package sNPLS

Hervas, D.; (...); Ferrer, A.

Article. 10.1016/j.chemolab.2018.06.005. 2018

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts

Zeidan, AM; (...); Mascarenhas, J

Review. 10.1016/S2352-3026(20)30205-2. 2020

Specific plasma micro-RNA profiles for prediction of recurrence in Crohn's disease in pre-surgery and established recurrence scenarios

Moret, I; (...); Beltran, B

Meeting Abstract. 2020

State of the art of Mohs surgery for rare cutaneous tumors in the Spanish Registry of Mohs Surgery (REGESMOHS).

Rodríguez-Jiménez P; (...); Descalzo MA

Article. 10.1111/ijd.14732. 2020

Stem cell paracrine actions in tissue regeneration and its potential therapeutic effect in human endometrium: a retrospective study.

de Miguel-Gómez L; (...); Cervelló I

Article. 10.1111/1471-0528.16078. 2020

Stem cell therapy induces a shift from an inflammatory environment towards an immune tolerant scenario promoting endometrial tissue regeneration

De Miguel-Gomez, L.; (...); Cervello, I.

Meeting Abstract. 2019

Stress and neurodegeneration.

Review. 10.1016/j.cca.2020.01.019. 2020

STUDY OF MUTATIONAL PROFILE AND CORRELATION OF RESPONSE TO EX VIVO PHARMACOLOGICAL TEST, IN THE DIAGNOSTIC OF THE AML

de la Fuente, EO; (...); Diaz, RA

Meeting Abstract. 2018

Study of the pathophysiological mechanisms associated with the onset and course of neurodevelopmental disorders in preterm infants (the PeriSTRESS-PremTEA study): Rationale, objectives, design and sample description.

Navalón P; (...); García-Blanco A

Article. 10.1016/j.rpsm.2021.02.002. 2021

STUDY OF TRANSCRIPTIONAL DIFFERENCES BETWEEN THE IDH2 R140 AND R172 MUTATIONS BY MEANS OF MODELING IN THE ORGANISM CAENORHABDITIS ELEGANS

Gonzalez, Romero Elisa; (...); Cervera, Jose Vicente

Meeting Abstract. 2020

Successful treatment of erythema nodosum leprosum with apremilast.

Abril-Perez, Carlos; (...); Botella-Estrada, Rafael

Letter. 10.1111/dth.15258. 2022

Successful treatment with imatinib of lymphomatoid papulosis associated with myeloproliferative hypereosinophilic syndrome with PDGFRA rearrangement.

Torres-Navarro I, de Unamuno-Bustos B, Botella-Estrada R

Case Reports. 10.1111/ddg.14064. 2020

Surfactant Administration via Thin Catheter: A Practical Guide.

Vento M; (...); Dargaville PA

Article. 10.1159/000502610. 2019

Survey shows marked variations in approaches to redirection of care for critically ill very preterm infants in 11 countries.

Helenius K; (...); International Network for Evaluation of Outcomes of neonates (iNeo)

Article. 10.1111/apa.15069. 2020

Survival analysis and sentinel lymph node status in thin cutaneous melanoma: A multicenter observational study.

Tejera-Vaquerizo, A; (...); SENTIMEL group

Article. 10.1002/cam4.2358. 2019

Survival in Very Preterm Infants: An International Comparison of 10 National Neonatal Networks

Helenius, K; (...); Lehtonen, L

Editorial Material. 10.1097/OGX.0000000000000553. 2018

Survival of Patients with Acute Myeloid Leukemia According to Age in a University Hospital in Colombia

Melo, CLS; (...); Montesinos, P

Meeting Abstract. 2021

Survival of Patients with Acute Myeloid Leukemia, Taken to Hematopoietic Stem Cell Transplantation: Experience of A Center in Colombia

Melo, CLS; (...); Ortiz, MF

Meeting Abstract. 2021

Survival of Patients with Secondary Acute Myeloid Leukemia in a University Hospital in Colombia

Ortiz, MF; (...); Sossa, C

Meeting Abstract. 2021

Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy

Cortes, JE; (...); Heuser, M

Article. 10.1186/s13045-020-00929-8. 2020

Symmetrical pustulosis unfolds over systemic lupus.

Abril-Perez, Carlos; (...); Botella-Estrada, Rafael

Article. 10.1093/rheumatology/keab529. 2021

Synergistic activation of AMPK prevents from polyglutamine-induced toxicity in Caenorhabditis elegans.

Gómez-Escribano AP; (...); Vázquez-Manrique RP

Article. 10.1016/j.phrs.2020.105105. 2020

SYNERGISTIC COMBINATIONS OF METFORMIN AND SALICYLATE REDUCE POLYGLUTAMINE TOXICITY IN C. ELEGANS

Bono-Yague, Jose; (...); Vazquez-Manrique, Rafael

Meeting Abstract. 10.1136/jnnp-2018-EHDN.256. 2018

Systematic review of BRAF/MEK inhibitors-induced Severe Cutaneous Adverse Reactions (SCARs).

Review. 10.1111/jdv.16894. 2020

Systemic therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: a SCORTEN-based systematic review and meta-analysis.

Torres-Navarro I, Briz-Redón Á, Botella-Estrada R

Review. 10.1111/jdv.16685. 2020

Systemic therapies for toxic epidermal necrolysis and Stevens-Johnson syndrome: A SCORTEN-based systematic review and meta-analysis

Torres Navarro, Ignacio; (...); Botella-Estrada, Rafael

Meeting Abstract. 2020

t(1;19)(q23;p13) TCF3-PBX1 May Not Be an Intermediate-Risk Subtype in Adult B-Cell Precursor Acute Lymphoblastic Leukemia Patients Treated With MRD-Oriented Protocols from the PETHEMA Group

Ribera, J; (...); Ribera, JM

Meeting Abstract. 2021

Targeting Oxygen in Term and Preterm Infants Starting at Birth

Vento, M, Saugstad, OD

Article. 10.1016/j.clp.2019.05.013. 2019

Telomerase Expression in a Series of Melanocytic Neoplasms

Bustos, BD; (...); Estrada, RB

Article. 10.1016/j.ad.2018.10.003. 2019

Testing for minimal residual disease in adults with acute lymphoblastic leukemia in Europe: a clinician survey

Pigneux, A; (...); Bruggemann, M

Article. 10.1186/s12885-018-5002-5. 2018

The association between dermoscopic features and BRAF mutational status in cutaneous melanoma: Significance of the blue-white veil

Armengot-Carbo, M; (...); Botella-Estrada, R

Article. 10.1016/j.jaad.2017.12.064. 2018

THE COMBINATION OF GENOMIC ANALYSIS AND MINIMAL RESIDUAL DISEASE IMPROVES THE STRATIFICATION OF ADULT PATIENTS WITH TYPE T-LYMPHOBLASTIC LEUKEMIA (LAL-T) TREATED ACCORDING TO THE PETHEMA PROTOCOLS

Gonzalez Gil, C.; (...); Genesca Ferrer, E.

Meeting Abstract. 2021

The Effect of Morbidity and Sex on Postnatal Growth of Very Preterm Infants: A Multicenter Cohort Study

Zozaya, C; (...); de Pipaon, MS

Article. 10.1159/000497221. 2019

The Effectiveness of an Oral Sensorimotor Stimulation Protocol for the Early Achievement of Exclusive Oral Feeding in Premature Infants. A Randomized, Controlled Trial.

Aguilar-Rodríguez M; (...); Vento-Torres M

Article. 10.1080/01942638.2019.1698688. 2020

The Evolving Microbiome from Pregnancy to Early Infancy: A Comprehensive Review.

Mesa MD; (...); Cabañas F

Review. 10.3390/nu12010133. 2020

The Female Sexual Function Index to assess patients with moderate to severe vulvar lichen sclerosus.

Gutierrez-Ontalvilla P; (...); Vicente D

Letter. 10.1684/ejd.2019.3580. 2019

The First Real-World Evidence Prospective Registry of Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm Treated with Tagraxofusp, a CD123-Targeted Therapy, in Europe

Platzbecker, Uwe; (...); Mohty, Mohamad

Meeting Abstract. 10.1182/blood-2021-145099. 2021

The Impact of Postnatal Systemic Steroids on the Growth of Preterm Infants: A Multicenter Cohort Study.

Zozaya C; (...); Saenz de Pipaón M

Article. 10.3390/nu11112729. 2019

The Influence of Donor Milk Supplementation on Duration of Parenteral Nutrition in Preterm Infants.

Chinea Jiménez B; (...); Saenz de Pipaon M

Article. 10.1177/0890334419892908. 2020

The International Network for Evaluating Outcomes (iNeo) of neonates: evolution, progress and opportunities

Shah, Prakesh S.; (...); Int Network Evaluating Outcomes iN

Review. 10.21037/tp.2019.07.06. 2019

The modular network structure of the mutational landscape of Acute Myeloid Leukemia

Ibanez, M; (...); Cervera, J

Article. 10.1371/journal.pone.0202926. 2018

The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial

Ayala, R; (...); Montesinos, P

Article. 10.3390/cancers13102458. 2021

The Oxygen Load Supplied during Delivery Room Stabilization of Preterm Infants Modifies the DNA Methylation Profile

Lorente-Pozo, Sheila; (...); Vento, Maximo

Article. 10.1016/j.jpeds.2018.07.009. 2018

The poor prognosis of low hypodiploidy in adults with B-cell precursor acute lymphoblastic leukaemia is restricted to older adults and elderly patients

Ribera, J; (...); Ribera, JM

Article. 10.1111/bjh.15887. 2019

The QUAZAR AML-001 maintenance trial: Results of a phase III international, randomized, double-blind, placebo-controlled study of oral CC-486 in patients with Acute Myeloid Leukemia (AML) in first remission

Dohner, H; (...); Roboz, GJ

Meeting Abstract. 2020

The Relationship between Oxidative Stress, Intermittent Hypoxemia, and Hospital Duration in Moderate Preterm Infants.

Shah VP; (...); Di Fiore JM

Article. 10.1159/000509038. 2020

The role of attentional biases to appetitive stimuli in childhood overweight

Rojo-Bofill, LM; (...); Garcia-Blanco, A

Article. 10.1016/j.jecp.2019.04.014. 2019

THE ROLE OF CXCL4, CXCL8 AND GDF-15 IN SYSTEMIC SCLEROSIS

Rodriguez, JEO; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2020-eular.5019. 2020

The vertebroplacental ratio as an alternative to the cerebroplacental ratio in the evaluation of the fetus at the end of pregnancy

Morales-Rosello, J; (...); Perales-Marin, A

Article. 10.1080/14767058.2016.1275551. 2018

Time and Cost of Hospitalisation for Salvage Therapy in Adults with Philadelphia Chromosome-Negative B Cell Precursor Relapsed or Refractory Acute Lymphoblastic Leukaemia in Spain

Boluda, B; (...); Montesinos, P

Article. 10.1007/s41669-018-0098-8. 2019

Topiramate pharmacokinetics in neonates undergoing therapeutic hypothermia and proposal of an optimised dosing schedule.

Marques MR; (...); Mangas-Sanjuan V

Article. 10.1111/apa.14944. 2020

Topiramate plus Cooling for Hypoxic-Ischemic Encephalopathy: A Randomized, Controlled, Multicenter, Double-Blinded Trial

Nunez-Ramiro, A; (...); Hypotop Study Grp

Article. 10.1159/000499084. 2019

Toxic epidermal necrolysis with severe hepatic involvement

Torres-Navarro, I; (...); Botella-Estrada, R

Letter. 10.1111/ddg.14110. 2020

Toxische epidermale Nekrolyse mit schwerer hepatischer Beteiligung.

Letter. 10.1111/ddg.14110_g. 2020

Trajectories of stress biomarkers and anxious-depressive symptoms from pregnancy to postpartum period in women with a trauma history

Ghosn, F; (...); Blanco, AG

Article. 10.1080/20008198.2019.1601990. 2019

TRANSCRIPTIONAL CHARACTERIZATION OF ACUTE MYELOID LEUKEMIA AT DIAGNOSIS IN THE ELDERLY PATIENT WITH IDENTIFICATION OF NEW PROGNOSTIC GROUPS

Sara, Villar; (...); Pau, Montesinos

Meeting Abstract. 2021

Transcriptome profiles discriminate between Gram-positive and Gram-negative sepsis in preterm neonates.

Cernada M; (...); Serna E

Article. 10.1038/s41390-021-01444-3. 2021

TRANSCRIPTOMICAL ANALYSIS AND MODELING IN C.ELEGANS OF THE IDH2 R140 R172 MUTATION

Gonzalez-Romero, E.; (...); Cervera-Zamora, J., V

Meeting Abstract. 2019

Treatment of acute promyelocytic leukemia in older patients: recommendations of an International Society of Geriatric Oncology (SIOG) task force.

Klepin HD; (...); Cordoba R

Review. 10.1016/j.jgo.2020.03.019. 2020

Treatment of Frail Older Adults and Elderly Patients With Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia: Results of a Prospective Trial With Minimal Chemotherapy

Ribera, JM; (...); Spanish Soc Hematology

Article. 10.1016/j.clml.2020.03.011. 2020

Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study.

Martínez-Cuadrón D; (...); Montesinos P

Article. 10.1182/bloodadvances.2021005335. 2022

Treatment Persistence and Safety of Apremilast in Psoriasis: Experience With 30 Patients in Routine Clinical Practice

Sahuquillo-Torralba, A; (...); Estrada, RB

Article. 10.1016/j.ad.2018.10.031. 2020

Trends in Outcomes for Neonates Born Very Preterm and Very Low Birth Weight in 11 High-Income Countries.

Lui K; (...); International Network for Evaluation of Outcomes (iNeo) of neonates Investigator

Article. 10.1016/j.jpeds.2019.08.020. 2019

Tumour-infiltrating lymphocyte and histological regression in primary melanoma.

Ribero S, Torres-Navarro I, Botella-Estrada R

Letter. 10.1007/s00403-020-02089-8. 2021

Tyrosine kinase inhibitors for acute myeloid leukemia: A step toward disease control?

Torres-Navarro I, Sahuquillo-Torralba A, Botella-Estrada R

Review. 10.1016/j.blre.2020.100675. 2020

Umbilical cord milking reduces the risk of intraventricular hemorrhage in preterm infants born before 32 weeks of gestation

Toledo, J. D.; (...); Vento, M.

Article. 10.1038/s41372-019-0329-6. 2019

Unique clinico-biological, genetic and prognostic features of adult early T cell precursor acute lymphoblastic leukemia.

Genescà E; (...); Ribera JM

Letter. 10.3324/haematol.2019.225078. 2020

Unit-Level Variations in Healthcare Professionals' Availability for Preterm Neonates 29 Weeks' Gestation: An International Survey.

Shahroor M; (...); on behalf of the International Network for Evaluation of Outcomes (iNeo) of neon

Article. 10.1159/000501801. 2019

Unraveling IKZF1 Deletion Therapeutic Vulnerabilities in Adult B-Cell Precursor Acute Lymphoblastic Leukemia

Ribera, Jordi; (...); Maria Ribera, Josep

Meeting Abstract. 2020

Update on management and progress of novel therapeutics for R/R AML: an Iberian expert panel consensus.

Montesinos P; (...); Sanz MÁ

Article. 10.1007/s00277-019-03820-w. 2019

Updated results from DIAMOND-01 (CLI24-001) trial: A phase I/II study of SEL24/MEN1703, a first-in-class dual PIM/FLT3 kinase inhibitor, in acute myeloid leukemia.

Solomon, Scott R.; (...); Ravandi, Farhad

Meeting Abstract. 10.1200/JCO.2021.39.15_suppl.7023. 2021

Urticaria multiforme, an "erythema multiforme" simulator.

Article. 10.1016/j.medcli.2017.11.046. 2018

Use of Azacitidine or Decitabine for the Up-Front Setting in Acute Myeloid Leukaemia: A Systematic Review and Meta-Analysis.

Saiz-Rodriguez, M; (...); Montesinos, P

Article. 10.3390/cancers13225677. 2021

Use of near infrared spectroscopy in neonatal gastric perforation.

Torres-Martínez E; (...); Solaz-García Á

Article. 10.1016/j.anpede.2021.06.004. 2021

Uso de la espectroscopia cercana al infrarrojo en las perforaciones gástricas en neonatología.

Torres-Martínez E; (...); Solaz-García Á

Case Reports. 10.1016/j.anpedi.2021.01.018. 2021

Validated analytical method to determine new salivary lipid peroxidation compounds as potential neurodegenerative biomarkers.